臨床に直結する集中治療のエビデンス

出版社: 文光堂
著者:
発行日: 2013-02-26
分野: 臨床医学:一般  >  集中治療
ISBN: 9784830626272
電子書籍版: 2013-02-26 (第1版第3刷)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:8~14営業日

13,200 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

13,200 円(税込)

商品紹介

第一線の集中治療の現場で奮闘する若手医師から発せられた臨床上のナマの疑問点を集めて目次に集約。これらの疑問点に基づいて,(1)その背景およびその分野における歴史や生理学的知識を整理して疑問点の所在を明らかにし,(2)疑問点に関する主要な研究を一覧表にまとめ,(3)その中から重要な論文を採りあげて批判的吟味を行い,(4)現時点で最も妥当な考え方を提示する内容構成。良質なメタ解析や無作為化対照試験に限らず,必要に応じて観察研究も採用して十分な検討を加えた。エビデンスがない(現時点で,その治療を行う根拠を見いだせない)場合にも,エビデンスがない旨を明記しつつ,その上で妥当な臨床判断を提供できるよう心がけた。明日からの,ICUや救急病棟の臨床を心強くサポートする1冊!

目次

  • 臨床に直結する集中治療のエビデンス

    ―目次―

    総 論
    神 経
    呼 吸
    循 環
    腎・泌尿器,電解質,輸液
    腹部,栄養
    内分泌,代謝
    感 染
    血液・凝固
    外傷・熱傷
    心肺蘇生

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

総論

P.6 掲載の参考文献
2) Kelley MA. Predictive scoring systems in the intensive care unit. In : Basow DS, ed, UpToDate, Waltham, MA, 2012.
9) Vincent JL. Severity of illness scoring systems. In : Roberts PR, ed, Comprehensive Critical Care : Adult, IL : Society of Critical Care Medicine, 2012 : 875-84.
10) http://www.jseptic.com/rinsho/questionnaire.html
11) Marino PL. 臨床的スコアリングシステム. In : 稲田英一監訳, ICUブック, 第3版, 東京 : メディカル・サイエンス・インターナショナル, 2008 : 865-68.
13) https://apachefoundations.cernerworks.com/apachefoundations/login/auth
16) http://www.mecriticalcare.net/icu_scores/apacheIV.php
20) http://www.saps3.org/
P.12 掲載の参考文献
1) ACR appropriateness criteria-routine chest radiograph. American College of Radiology 2011. http://www.acr.org/~/media/ACR/Documents/AppCriteria/Diagnostic/RoutineChestRadiographsInICUPatients.pdf

神経

P.21 掲載の参考文献
11) Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke. Circulation 2007 ; 115 : e478-e534.
28) Murphy-Human T, Welch E, Zipfel G, et al. Comparison of short-duration levetiracetam with extended-course phenytoin for seizure prophylaxis after subarachnoid hemorrhage. World Neurosurg 2011 ; 75 : 269-274.
30) Woo KM, Yang SY, Cho KT. Seizures after spontaneous intracerebral hemorrhage. J Korean Neurosurg Soc 2012 ; 52 : 312-9.
P.33 掲載の参考文献
1) 主要死因別死亡者数, 総務省統計局・政策統括官・統計研修所ホームページ, http://www.stat.go.jp/data/nihon/g4921.htm (平成24年10月25日アクセス)
5) Ecker A, Riemenschneider PA. Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms. J Neurosurg 1951 ; 8 : 660-7.
9) Philippon J, Grob R, Dagreou F, et al. Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir (Wien) 1986 ; 82 : 110-4.
11) Petruk KC, West M, Mohr G, et al. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 1988 ; 68 : 505-17.
12) Jan M, Buchheit F, Tremoulet M. Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms. Neurosurgery 1988 ; 23 : 154-7.
15) Haley EC Jr, Kassell NF, Torner JC. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 1993 ; 78 : 537-47.
19) Soppi V, Karamanakos PN, Koivisto T, et al. A randomized outcome study of enteral versus intravenous nimodipine in 171 patients after acute aneurysmal subarachnoid hemorrhage. World Neurosurg 2012 ; 78 : 101-9.
22) Wong GK, Chan MT, Boet R, et al. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage : a prospective randomized pilot study. J Neurosurg Anesthesiol 2006 ; 18 : 142-8.
24) Westermaier T, Stetter C, Vince GH, et al. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage : a randomized, placebo-controlled, clinical study. Crit Care Med 2010 ; 38 : 1284-90.
28) Tseng MY, Czosnyka M, Richards H, et al. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage : a phase II randomized placebo-controlled trial. Stroke 2005 ; 36 : 1627-32.
29) Lynch JR, Wang H, McGirt MJ, et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage : results of a pilot randomized clinical trial. Stroke 2005 ; 36 : 2024-6.
30) Chou SH, Smith EE, Badjatia N, et al. A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke 2008 ; 39 : 2891-3.
33) Simvastatin in Aneurysmal Subarachnoid Haemorrhage (STASH) a Multicentre Randomised Controlled Clinical Trial, http://www.clinicaltrials.gov/ct2/show/NCT00731627 (平成24年11月13日アクセス)
37) Egge A, Waterloo K, Sjoholm H, et al. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage : a clinical, prospective, randomized, controlled study. Neurosurgery 2001 ; 49 : 593-605.
38) Treggiari MM, Deem S. Which H is the most important in triple-H therapy for cerebral vasospasm? Curr Opin Crit Care 2009 ; 15 : 83-6.
40) Ekelund A, Reinstrup P, Ryding E, et al. Effects of iso-and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien) 2002 ; 144 : 703-12.
P.42 掲載の参考文献
1) Brain Trauma Foundation ; American Association of Neurological Surgeons ; Congress of Neurological Surgeons ; Joint Section on Neurotrauma and Critical Care, AANS/CNS, Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. I. Blood pressure and oxygenation. J Neurotrauma 2007 ; 24 (suppl 1) : S1-7
2) Brain Trauma Foundation ; American Association of Neurological Surgeons ; Congress of Neurological Surgeons ; Joint Section on Neurotrauma and Critical Care, AANS/CNS, Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. IX. Cerebral perfusion thresholds. J Neurotrauma 2007 ; 24 (suppl 1) : S59-64.
7) Shafi S, Diaz-Arrastia R, Madden C, et al. Intracranial pressure monitoring in brain-injured patients is associated with worsening of survival. J Trauma 2008 ; 64 : 335-40.
11) Brain Trauma Foundation ; American Association of Neurological Surgeons ; Congress of Neurological Surgeons ; Joint Section on Neurotrauma and Critical Care, AANS/CNS. Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. VIII. Intracranial pressure thresholds J Neurotrauma 2007 ; 24 (suppl 1) : S55-8.
12) Fearnside MR, Cook RJ, McDougall P, et al. The Westmead Head Injury Project outcome in severe head injury. A comparative analysis of pre-hospital, clinical and CT variables. Br J Neurosurg 1993 ; 7 : 267-79.
13) Chesnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma 1993 ; 34 : 216-22.
14) Manley G, Knudson MM, Morabito D, et al. Hypotension, hypoxia, and head injury : frequency, duration, and consequences. Arch Surg 2001 ; 136 : 1118-23.
22) Schreiber MA, Aoki N, Scott BG, et al. Determinants of mortality in patients with severe blunt head injury. Arch Surg 2002 ; 137 : 285-90.
27) Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) investigators. Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med 2010 ; 38 : 637-48.
30) Delcourt C, Huang Y, Wang J, et al. The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT 2). Int J Stroke 2010 ; 5 : 110-6.
P.51 掲載の参考文献
1) Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999 ; 54 : 1136-42.
3) FDA. HIGHLIGHTS OF PRESCRIBING INFORMATION. Precedex (dexmedetomidine hydrochloride) injection.
P.60 掲載の参考文献
2) American Psychiatric Association. Diagnostic and statistical manual of mental disorders. text revision. 4th ed, Washington D. C., American Psychiatric Association, 2000.
7) Spronk PE, Riekerk B, Hofhuis J, et al. Occurrence of delirium is severely underestimated in the ICU during daily care. Intensive Care Med 2009 ; 35 : 1276-80.
20) Rockwood K, Cosway S, Carver D, et al. The risk of dementia and death after delirium. Age Ageing 1999 ; 28 : 551-6.
22) Edelstein DM, Aharonoff GB, Karp A, et al. Effect of postoperative delirium on outcome after hip fracture. Clin Orthop Relat Res 2004 ; (422) : 195-200.
24) Murray AM, Levkoff SE, Wetle TT, et al. Acute delirium and functional decline in the hospitalized elderly patient. J Gerontol 1993 ; 48 : M181-6.
27) McCusker J, Cole M, Dendukuri N, et al. Delirium in older medical inpatients and subsequent cognitive and functional status : a prospective study. CMAJ 2001 ; 165 : 575-83.
29) Mahoney FI, Barthel DW. Functional Evaluation : The Barthel Index. Md State Med J 1965 ; 14 : 61-5.
30) Fillenbaum G. Multidimensional Functional Assessment : The OARS Methodology-A Manual, 2nd ed, Duke University, Center for the Study of Aging and Human Development, 1978.
37) Cole MG, McCusker J, Bellavance F, et al. Systematic detection and multidisciplinary care of delirium in older medical inpatients : a randomized trial. CMAJ 2002 ; 167 : 753-9.
50) Cole MG, Primeau FJ, Bailey RF, et al. Systematic intervention for elderly inpatients with delirium : a randomized trial. CMAJ 1994 ; 151 : 965-70.
P.69 掲載の参考文献
5) Osuka A, Uno T, Nakanishi J, et al. Energy expenditure in patients with severe head injury : Controlled normothermia with sedation and neuromuscular blockade. J Crit Care 2012 Jul 24. PMID : 22835423
21) Deem S. Intensive-care-unit-acquired muscle weakness. Respir Care 2006 ; 51 : 1042-52 ; discussion 1052-3. PMID : 16934167
36) Lofberg E, Gutierrez A, Wernerman J, et al. Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle. Eur J Clin Invest 2002 ; 32 : 345-53. PMID : 12027875
37) Kesler SM, Sprenkle MD, David WS, et al. Severe weakness complicating status asthmaticus despite minimal duration of neuromuscular paralysis. Intensive Care Med 2009 ; 35 : 157-60. PMID : 18807012
P.78 掲載の参考文献
2) 日本呼吸療法医学会人工呼吸中の鎮静ガイドライン作成委員会 : 人工呼吸中の鎮静のためのガイドライン. http://square.umin.ac.jp/jrcm/contents/guide/page03.html
21) Mehta S, Burry L, Cook D, et al. Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol. JAMA 2012 ; 308 : e1-e8.
22) Jackson JC, Girard TD, Gordon SM, et al. Long-term cognitive and psychological outcomes in the awakening and breathing controlled trial. Am J Respir Crit Care Med 2010 ; 182 : 183-91.
23) Kress JP, Gehlbach B, Lacy M, et al. The long-term psychological effects of daily sedative interruption on critically ill patients. Am J Respir Crit Care Med 2003 ; 168 : 1457-61.

呼吸

P.86 掲載の参考文献
14) Girgis K, Hamed H, Khater Y, et al, A decremental PEEP trial identifies the PEEP level that maintains oxygenation after lung recruitment. Respir Care 2006 ; 51 : 1132-9.
P.96 掲載の参考文献
7) Esteban A, et al. A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group. N Engl J Med 1995 ; 332 : 345-50.
11) Butler R, et al. Is there a preferred technique for weaning the difficult-to-wean patient? A systematic review of the literature. Crit Care Med 1999 ; 27 : 2331-6.
14) Ma YM, Liu YN, Pan L. [The effect of spontaneous breathing trial on weaning from ventilators]. Zhonghua Jie He He Hu Xi Za Zhi 2010 ; 33 : 179-82.
15) Ma YJ, et al. [Comparison of computer-driven weaning and physician-directed weaning from mechanical ventilation : a randomized prospective study]. Zhonghua Jie He He Hu Xi Za Zhi 2010 ; 33 : 174-8.
16) Grigolia GN, et al. [Transition of patients to spontaneous respiration after a prolonged mechanical ventilation with the involvement of various methods of auxiliary ventilation]. Georgian Med News 2006 ; 141 : 7-10.
17) Cekmen N, Erdemli O. The comparison of the effects of T-piece and CPAP on hemodynamic parameters, arterial blood gases and success of weaning. Bratisl Lek Listy 2011 ; 112 : 512-6.
21) Matic I, et al. Chronic obstructive pulmonary disease and weaning of difficult-to-wean patients from mechanical ventilation : randomized prospective study. Croat Med J 2007 ; 48 : 51-8.
22) Matic I, Majeric-Kogler V. Comparison of pressure support and T-tube weaning from mechanical ventilation : randomized prospective study. Croat Med J 2004 ; 45 : 162-6.
24) Figueroa-Casas, JB., et al. Comparison between automatic tube compensation and continuous positive airway pressure during spontaneous breathing trials. Respir Care 2010 ; 55 : 549-54.
26) Esteban A, et al. Effect of spontaneous breathing trial duration on outcome of attempts to discontinue mechanical ventilation. Spanish Lung Failure Collaborative Group. Am J Respir Crit Care Med 1999 ; 159 : 512-8.
30) Molina-Saldarriaga FJ, et al. [Spontaneous breathing trial in chronic obstructive pulmonary disease : continuous positive airway pressure (CPAP) versus T-piece]. Med Intensiva 34 : 453-8.
32) East TD, et al. Efficacy of computerized decision support for mechanical ventilation : results of a prospective multi-center randomized trial. Proc AMIA Symp, 1999 ; 251-5.
36) Chaiwat O, et al. Protocol-directed vs. physician-directed weaning from ventilator in intra-abdominal surgical patients. J Med Assoc Thai 2010 ; 93 : 930-6.
45) Simeone F, et al. Optimization of mechanical ventilation support following cardiac surgery. J Cardiovasc Surg (Torino) 2002 ; 43 : 633-41.
48) Piotto RF, et al. Effects of the use of mechanical ventilation weaning protocol in the Coronary Care Unit : randomized study. Rev Bras Cir Cardiovasc 2011 ; 26 : 213-21.
49) Jiang H, S. Y. Yu, and L. W. Wang [Comparison of SmartCare and spontaneous breathing trials for weaning old patients with chronic obstructive pulmonary diseases]. Zhonghua Jie He He Hu Xi Za Zhi 2006 ; 29 : 545-8.
P.102 掲載の参考文献
3) Myers TR, MacIntyre NR. Respiratory controversies in the critical care setting. Does airway pressure release ventilation offer important new advantages in mechanical ventilator support? Respir Care 2007 ; 52 : 452-8 ; discussion 458-60. PubMed PMID : 17417979.
6) Zhang NX, Qin YZ, Xu L, et al. [Clinical comparative study of airway pressure release ventilation and continuous positive airway pressure ventilation]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2005 ; 17 : 481-3. Chinese. PubMed PMID : 16105427.
13) Liu L, Tanigawa K, Ota K, et al. Practical use of airway pressure release ventilation for severe ARDS -a preliminary report in comparison with a conventional ventilatory support. Hiroshima J Med Sci 2009 ; 58 (4) : 83-8. PubMed PMID : 20349751.
14) Gonzalez M, Arroliga AC, Frutos-Vivar F, et al. Airway pressure release ventilation versus assist-control ventilation : a comparative propensity score and international cohort study. Intensive Care Med 2010 ; 36 : 817-27. PubMed PMID : 20229042.
P.111 掲載の参考文献
2) Estenssoro E, Dubin A, Laffaire E, et al. Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome. Crit Care Med 2002 ; 30 : 2450-6.
5) Ashbaugh DG, Bigelow DB, Petty TL, et al. Acute respiratory distress in adults. Lancet 1967 ; 2 : 319-23.
13) 讃井將満 : ARDSに対する非人工呼吸療法, 薬物療法を中心に : 過去, 現在, 未来- (3) ECMO, PCPSなどの体外循環. INTENSIVIST 2009 ; 1 : 91-95.
16) Wylie WD, Churchill-Davidson HC. A Practice of Anaesthesia, 3rd ed, Lloyd-Luke, London, 1972, 691-715.
17) Von Frey M, Gruber M. Untersuchungen uber den Stoffwechselisolierter Organe. Ein respirations-apparat fur isoisolierte organe. Virchow's Arch Physiol 1885 ; 9 : 519-32.
18) 新見能成監訳. 人工心肺-その原理と実際-MEDSI, 東京, 2010, 18-23.
33) Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998 ; 338 : 347-54.
35) http://www.clinicaltrials.gov/ct2/show/NCT01470703?term=EOLIA&rank=1
36) http://www.nslhd.health.nsw.gov.au/ppg/PD2010_028.pdf
37) REVA organization, SDRA liea la grippe A (H1N1) -2009, Recommandations pour l'assistance respiratoire ; 2009. http://www.srlf.org/rc/org/srlf/htm/Article/2011/20110903-134333-752/src/htm_fullText/fr/20090927_REVAGRIP_SDRA_grippe_A_H1N1_Recommandations_assistance_respiratoire.pdf. [Accessed 15 September 2011]
47) Ullrich R, Lorber C, Roder G, et al. Anesthesiology. Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS 1999 ; 91 : 1577-86.
49) Linden V, Palmer K, Reinhard J, et al. High survival in adult patients with acute respiratory distress syndrome treated by extracorporeal membrane oxygenation, minimal sedation, and pressure supported ventilation. Intensive Care Med 2000 ; 26 : 1630-7.
51) Frenckner B, Palmer P, Linden V. Extracorporeal respiratory support and minimally invasive ventilation in severe ARDS. Minerva Anesthesiol 2002 ; 68 : 381-6.
59) 方山真朱, 熊澤淳史, 大江恭司ほか. H1N1インフルエンザによる重症肺炎に対し膜型人工肺を用い救命した1例. 日集中医誌 2011 ; 18 ; 405-9
63) World Health Organization. Human infection with new influenza A (H1N1) virus : clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec 2009 ; 84 : 185-9.
72) Extracorporeal Life Support Organization. ECMO Registry Report of the ELSO : International Summary. ELSO, Ann Arbor, Michigan ; January 2012 http://www.elso.med.umich.edu/DataRequests.html
74) 中谷武嗣 : レジストリー. 新版経皮的人工心肺補助法 : PCPSの最前線, 松田暉監修, 秀潤社, 東京, 2004, 141-8
78) 藤倉一郎. 人工心肺の発達史. 人工臓器 1972 ; 1 (2)
79) up to date. Extracorporeal membrane oxygenation (ECMO) in adults
80) Bartlett RH, Gattinoni L. Current status of extracorporeal life support (ECMO) for cardiopulmonary failure. Minerva Anesthesiol 2010 ; 76 : 534-40.
P.124 掲載の参考文献
9) Combes A, Costa MA, Trouillet JL, et al. Morbidity, mortality, and quality-of-life outcomes of patients requiring > or=14 days of mechanical ventilation. Crit Care Med 2003 ; 31 : 1373-81.
18) Alexiou VG, Ierodiakonou V, Dimopoulos G, et al. Impact of patient position on the incidence of ventilator-associated pneumonia : a meta-analysis of randomized controlled trials. J Crit Care 2009 ; 24 : 515-22.
20) Pohlman MC, Schweickert WD, Pohlman AS, et al. Feasibility of physical and occupational therapy beginning from initiation of mechanical ventilation. Crit Care Med 2010 ; 38 : 2089-94.
27) O'Connor ED, Walsham J. Should we mobilise critically ill patients? A review. Crit Care Resusc 2009 ; 11 : 290-300.
30) Ntoumenopoulos G, Presneill JJ, McElholum M, et al. Chest physiotherapy for the prevention of ventilator-associated pneumonia. Intensive Care Med 2002 ; 28 : 850-6.
37) Abroug F, Ouanes-Besbes L, Dachraoui F, et al. An updated study-level meta-analysis of randomised controlled trials on proning in ARDS and acute lung injury. Crit Care 2011 ; 15 : R6.
38) Castro AA, Calil SR, Freitas SA, et al. Chest physiotherapy effectiveness to reduce hospitalization and mechanical ventilation length of stay, pulmonary infection rate and mortality in ICU patients. Respir Med 2012 Oct 18. pii : S0954-6111 (12) 00357-5. doi : 10.1016/j.rmed.2012.09.016. [Epub ahead of print]
P.132 掲載の参考文献
3) Griggs WM, Worthley LI, Gilligan JE, et al. A simple percutaneous tracheostomy technique. Surg Gynecol Obstet 1990 ; 170 : 543-5. PMID : 2343371.
6) Zgoda MA, Berger R. Balloon-facilitated percutaneous dilational tracheostomy tube placement : preliminary report of a novel technique. Chest 2005 ; 128 : 3688-90. PMID : 16304334.
7) 内野滋彦. JSEPTIC簡単アンケート. 第9弾 : 気管切開. INTENSIVIST 2012 ; 4 : 406-9.
9) Veenith T, Ganeshamoorthy S, Standley T, et al. Intensive care unit tracheostomy : a snapshot of UK practice. Int Arch Med 2008 ; 1 : 21. PMID : 18950520.
12) Friedman Y, Fildes J, Mizock B, et al. Comparison of percutaneous and surgical tracheostomies. Chest 1996 ; 110 : 480-5. PMID : 8697854.
18) Melloni G, Muttini S, Gallioli G, et al. Surgical tracheostomy versus percutaneous dilatational tracheostomy. A prospective-randomized study with long-term follow-up. J Cardiovasc Surg 2002 ; 43 : 113-21. PMID : 11803342.
25) Dulguerov P, Gysin C, Perneger TV, et al. Percutaneous or surgical tracheostomy : a meta-analysis. Crit Care Med 1999 ; 27 : 1617-25. PMID : 10470774.
34) Trouillet JL, Luyt CE, Guiguet M, et al. Early percutaneous tracheotomy versus prolonged intubation of mechanically ventilated patients after cardiac surgery : a randomized trial. Ann Intern Med 2011 ; 154 : 373-83. PMID : 21403073.
37) Al Dawood A, Haddad S, Arabi Y, et al. The safety of percutaneous tracheostomy in patients with coagulopathy or thrombocytopenia. Middle East J Anesthesiol 2007 ; 19 : 37-49. PMID : 17511181.
38) Pandian V, Vaswani RS, Mirski MA, et al. Safety of percutaneous dilational tracheostomy in coagulopathic patients. Ear Nose Throat J 2010 ; 89 : 387-95. PMID : 20737378.
48) Yurtseven N, Aydemir B, Karaca P, et al. PercuTwist : a new alternative to Griggs and Ciaglia's techniques. Eur J Anaesthesiol 2007 ; 24 : 492-7. PMID : 17207301.
52) Fikkers BG, Staatsen M, van den Hoogen FJ, et al. Early and late outcome after single step dilatational tracheostomy versus the guide wire dilating forceps technique : a prospective randomized clinical trial. Intensive Care Med 2011 ; 37 : 1103-9. PMID : 21484081.
P.139 掲載の参考文献
4) Campbell EJM. The J Burns Amberson Lecture. The management of acute respiratory failure in chronic bronchitis & emphysema. Am Rev Respir Dis 1967 ; 96 : 626-39.
12) Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease : a clinical trial. Ann Intern Med 1980 ; 93 : 391-8.
35) Keenan SP, Powers C, McCormack DG. Noninvasive positive pressure ventilation in patients with milder chronic obstructive pulmonary disease exacerbations : a randomized controlled trial. Respir Care 2005 ; 50 : 610-6.

循環

P.147 掲載の参考文献
8) Annane D, Vignon P, Renault A, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock : a randomised trial. Lancet 2007 ; 370 : 676-84.
11) Myburgh JA, Higgins A, Jovanovska A, et al. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 2008 ; 34 : 2226-34.
19) J ochberger S, Velik-Salchner C, Mayr VD, et al. The vasopressin and copeptin response in patients with vasodilatory shock after cardiac surgery : a prospective, controlled study. Intensive Care Med 2009 ; 35 : 489-97.
P.152 掲載の参考文献
48) Gutierrez J, Hossam A, Lazarezcu R, et al. Effect of beta blockers on sepsis outcome. Med Sci Monit 2009 ; 15 : CR499-503.
P.166 掲載の参考文献
21) Bakhsh M, Abbas S, Hussain RM, et al. Role of magnesium in preventing post-operative atrial fibrillation after coronary artery bypass surgery. J Ayub Med Coll Abbottabad 2009 ; 21 : 27-9. PMID 20524462.
24) Andrews TC, Reimold SC, Berlin JA, et al. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. Circulation 1991 ; 84 : III236-44. PMID 1682069.
39) Eslami M, Badkoubeh RS, Mousavi M, et al. Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting. Tex Heart Inst J 2007 ; 34 : 268-74. PMID 17948074.
43) Gerstenfeld EP, Khoo M, Martin RC, et al. Effectiveness of bi-atrial pacing for reducing atrial fibrillation after coronary artery bypass graft surgery. J Interv Card Electrophysiol 2001 ; 5 : 275-83. PMID 11500582.
P.180 掲載の参考文献
9) VISION Pilot Study Investigators, Devereaux PJ, Bradley D, et al. An international prospective cohort study evaluating major vascular complications among patients undergoing noncardiac surgery : the VISION Pilot Study. Open Med 2011 ; 5 : e193-200.
22) Thygesen K, Alpert JS, White HD ; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, et al. Universal definition of myocardial infarction. Circulation 2007 ; 116 : 2634-53.
25) Shammash JB, Kimmel SE, Devereaux PJ. Perioperative myocardial infarction after noncardiac surgery. (UpToDate online.) http://www.uptodate.com/contents/perioperative-myocardial-infarction-after-noncardiac-surgery?source=search_result&search=perioperative+myocardial+infarction&selectedTitle=1%7E36. (2012年11月30日アクセス)
40) Hamm CW, Bassand JP ; Authors/Task Force Members. ESC guidelines for the 18 management of acute coronary syndromes in patients presenting without persistent ST-segment elevation : the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011 ; 32 : 2999-3054.
P.188 掲載の参考文献
1) Schmidt M, Lindenauer PK, Fitzgerald JL, et al. Forecasting the impact of a clinical practice guideline for perioperative beta-blockers to reduce cardiovascular morbidity and mortality. Arch Intern Med 2002 ; 162 : 63-9. Epub 2002/02/05.
12) Juul AB, Wetterslev J, Gluud C, et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery : randomised placebo controlled, blinded multicentre trial. BMJ 2006 ; 332 : 1482. Epub 2006/06/24.
13) Zaugg M, Bestmann L, Wacker J, et al. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block : the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study : a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 2007 ; 107 : 33-44. Epub 2007/06/23.
14) Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery : Executive Summary : A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) : Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007 ; 116 : 1971-96. Epub 2007/09/29.
20) Kwon S, Thompson R, Florence M, et al. β-blocker continuation after noncardiac surgery : a report from the surgical care and outcomes assessment program. Arch Surg 2012 ; 147 : 467-73. Epub 2012/01/18.
21) Flu WJ, van Kuijk JP, Chonchol M, et al. Timing of pre-operative Beta-blocker treatment in vascular surgery patients : influence on post-operative outcome. J Am Coll Cardiol 2010 ; 56 : 1922-9. Epub 2010/11/27.
P.195 掲載の参考文献
4) Shoemaker WC, Appel PL, Kram HB, et al. Prospective trial of suprranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988 ; 94 : 1176-86.
5) Yu M, Levy M, Smith P, et al. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients : a prospective, randomized, controlled study. Crit Care Med 1993 ; 21 : 830-8.
20) Bellomo R, Ronco C, Kellum JA. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs : the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004 ; 8 : R204-12.
P.202 掲載の参考文献
5) National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006 ; 354 : 2564-75.
14) Barnwell BB, Edgecombe EW. The role of the central venous pressure determination in the management of the surgical patient. J Natl Med Assoc 1964 ; 56 : 482-6.
32) National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wheeler AP, Bernard GR, et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 2006 ; 354 : 2213-24.
49) Zhang HM, Liu DW, Wang XT, et al. Stroke volume variation in the evaluation of fluid responsiveness in refractory septic shock. Zhonghua Nei Ke Za Zhi 2010 ; 49 : 610-3.

腎・泌尿器, 電解質, 輸液

P.211 掲載の参考文献
17) 平島知圭, 和泉雅章, 三角文子ほか. 血液透析施行時におけるメシル酸ナファモスタットの先発品と後発品の比較検討. 透析会誌 2006 ; 39 : 105-10.
P.216 掲載の参考文献
1) Kidney Disease : Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Inter 2012 ; 2 suppl : 89-115.
9) Sabater J, Perez XL, Albertos R et al. Acute renal failure inseptic shock. Should we consider different continuous renal replacement therapies on each RIFLE score stage? Intensive Care Med 2009 ; 35 : S239.
11) Bagshaw SM, Wald R, Barton J, et al. Initiation of renal replacement therapy in critically ill patients with acute kidney injury ―a prospective multi-centre observational study [abstract]. Submitted to the 2010 AKI Critical Care Nephrology Conference, Edmonton, Canada, 2010.
22) Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs : the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004 ; 8 : R204-R12.
24) Kidney Disease : Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter 2012 ; 2 (suppl) : 19-36.
26) Weil MH, Shubin H. Centralized hospital care for the critically ill. Clin Anesth 1974 ; 10 : 127-35.
27) Ronco C, Brendolan A, Bellomo R. Continuous versus intermittent renal replacement therapy in the treatment of acute renal failure. Nephrol Dial Transplant 1998 ; 13 (suppl) 6 : 79-85.
P.223 掲載の参考文献
1) Hanasawa K, Tani T, Oka T, et al. Selective removal of endotoxin from the blood by extracorporeal hemoperfusion with polymyxin B immobilized fiber. Prog Clin Biol Res 1988 ; 264 : 337-41.
5) Effects of Hemoperfusion With a Polymixin B Membrane in Peritonitis With Septic Shock (ABDO-MIX). [cited ; Available from : http://clinicaltrials.gov/ct2/show/NCT01222663?term=ABDO-MIX&rank=1
6) Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Septic Shock (EUPHRATES). [cited ; Available from : http://clinicaltrials.gov/ct2/show/NCT01046669?term=EUPHRATES&rank=1
7) 草地信也, 渡邉学, 斉田芳久, et al. 日本の社会が求める周手術期感染対策とは何か? 日本外科感染症学会雑誌 2012 ; 9 : 225-31.
8) EUPHAS2 [. cited ; Available from : http://www.euphas2.eu/en/
23) Young P, Hodgson C, Dulhunty J, et al. End points for phase II trials in intensive care : recommendations from the Australian and New Zealand Clinical Trials Group consensus panel meeting. Crit Care Resusc 2012 ; 14 : 211-5.
P.229 掲載の参考文献
2) Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure -definition, outcome measures, animal models, fluid therapy and information technology needs : the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004 ; 8 : R204.
5) KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Kidney International Supplements (2012) 2, 124-138. http://www.kdigo.org/clinical_practice_guidelines/pdf/KDIGO%20AKI%20Guideline.pdf
6) Liangos O, Jaber BL. Nonoriguric acute tubular necrosis. UpToDate 20. 10, accessed on 10/25/2012.
11) Ho KM, Sheridan DJ. Meta-analysis of furosemide to prevent or treat acute renal failure. BMJ 2006 ; 21 : 1-6.
12) Karajala V, Manour W, Kellum JA, et al. Diuretics in acute kidney injury. Minerva Anesthesiol 2009 ; 75 : 251-7.
13) Ludens JH, Hook JB, Brody MJ, et al. Enhancement of renal blood flow by furosemide. J Pharmacol Exp Ther 1968 ; 163 : 456-60.
16) Hager B, Betschart M, Krapf R. Effect of postoperative loop diuretic on renal function after major surgery. Schweiz Med Wochenschr 1996 ; 126 : 666-73.
18) Shilliday IR, Quinn KJ, Allison MEM. Loop diuretics in the management of acute renal failure : a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant 1997 ; 12 : 2592-6.
21) Cantarovich F, Fernandez JC, Locatelli A, et al. Frosemide in high doses in the treatment of acute renal failure. Postgrad Med J 1971 ; 47 (suppl) : 13-7.
22) Brown CB, Ogg CS, Cameron JS. High dose frosemide in acute renal failure : a controlled trial. Clin Nephrol 1981 ; 15 : 90-6.
30) Marenzi G, Ferrari C, Marana I, et al. Prevention of Contrast Nephropathy by Furosemide with Matched Hydration : The MYTHOS (Induced Diuresis with Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) Trial. JACC 2012 ; 5 : 90-97.
P.236 掲載の参考文献
2) Rossing N. Intra-and extravascular distribution of albumin and immunoglobulin in man. Lymphology 1978 ; 11 : 138-42.
6) Bunn F, Lefebvre C, Li Wan Po A, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. The Albumin Reviewers. Cochrane Database Syst Rev 2000 ; 2 : CD001208.
7) Alderson P, Bunn F, Lefebvre C, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. The Albumin Reviewers. Cochrane Database Syst Rev 2002 ; 1 : CD001208.
15) The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006 ; 354 : 2564-75.
25) Bellomo R, Morimatsu H, Presneill J, et al. Effects of saline or albumin resuscitation on standard coagulation tests. Crit Care Resusc 2009 ; 11 : 250-6.
28) Palumbo D, Servillo G, D'Amato L, et al. The effects of hydroxyethyl starch solution in critically ill patients. Minerva Anesthesiol 2006 ; 72 : 655-64.
P.243 掲載の参考文献
9) National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006 ; 354 : 2564-75.
P.248 掲載の参考文献
4) Sezai A, Hata M, Niino T, et al. Influence of continuous infusion of low-dose human atrial natriuretic peptide on renal function during cardiac surgery : a randomized controlled study. J Am Coll Cardiol 2009 ; 54 : 1058-64.
5) Sezai A, Hata M, Niino T, et al. Continuous low-dose infusion of human atrial natriuretic peptide in patients with left ventricular dysfunction undergoing coronary artery bypass grafting : the NU-HIT (Nihon University working group study of low-dose Human ANP Infusion Therapy during cardiac surgery) for left ventricular dysfunction. J Am Coll Cardiol 2010 ; 55 : 1844-51.
14) UMIN000006812 心臓血管手術関連の急性腎傷害における心房性ナトリウム利尿ペプチドの腎保護効果と医療費評価 : 多施設共同ランダム比較試験. (Accessed 10/19, 2012, at https://upload.umin.ac.jp/cgi-openbin/ctr/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000007354&language=J.)
18) Izumi K, Eishi K, Yamachika S, et al. The efficacy of human atrial natriuretic peptide in patients with renal dysfunction undergoing cardiac surgery. Ann Thorac Cardiovasc Surg 2008 ; 14 : 294-302.
P.250 掲載の参考文献

腹部, 栄養

P.255 掲載の参考文献
P.262 掲載の参考文献
2) Heyland DK, Dhaliwal R, Drover JW, et al. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients update. 2009.
4) 氏家良人, 海塚安郎, 佐藤格夫ほか. 急性呼吸不全による人工呼吸患者の栄養管理ガイドライン 2011年版. 人工呼吸 2011 ; 29 : 75-120.
13) Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study). Clinical Trials. gov http://clinicaltrials.gov/ct2/show/NCT0069180
18) Pearce CB, Sadek SA, Walters AM, et al. A double-blind, randomised, controlled trial to study the effects of an enteral feed supplemented with glutamine, arginine, and omega-3 fatty acid in predicted acute severe pancreatitis. JOP 2006 ; 7 : 361-71.
P.268 掲載の参考文献
1) 小川道雄. 急性膵炎. プロテアーゼとそのインヒビター. 早石修監, メディカルビュー社, 東京, 1993 ; 275-83.
5) 角川陽一郎, 武田和憲, 砂村真琴ほか. 十二指腸盲管法による実験的急性膵炎に対する蛋白分解酵素阻害剤持続動注療法の効果. 日消誌 1990 ; 87 : 1444-50.
6) 福山尚治, 武田和憲, 松田和久ほか. 動注療法は膵perfusionを改善させるか. 日本腹部救急医学会雑誌 2005 ; 25 : 633-6.
19) 白井邦博, 丹正勝久, 篠原克浩ほか. メロペネムを用いた重症急性膵炎に対する膵局所動注療法の有効性 : イミペネムとの比較検討 : 無作為試験. 日本消化器外科学会雑誌 2008 ; 41 : 1-11.
24) Ishikawa T, Imai M, Kamimura H, et al. Therapeutic efficacy of continuous arterial infusion of the protease inhibitor and the antibiotics and via celiac and superior mesenteric artery for severe acute pancreatitis : pilot study. Hepatogastroenterology 2009 ; 56 : 524-8.
26) 山崎繁通, 横山昌典, 紙谷孝則ほか. 重症急性膵炎に対する持続動注療法-治療成績と動注カテーテル留置の工夫-. 日本腹部救急医学会雑誌 2005 ; 25 : 627-32.
27) 古屋智規, 高橋賢一, 橋爪隆弘ほか. 重症急性膵炎に対する動注療法の有効性と問題点. 日本腹部救急医学会雑誌 25 2005 ; 613-9.
P.275 掲載の参考文献
4) Carnovale A, Rabitti PG, Manes G, et al. Mortality in acute pancreatitis : is it an early or a late event? JOP 2005 ; 6 : 438-44.
10) Pederzoli P, Bassi C, Vesentini S, et al. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 1993 ; 176 : 480-3.
12) Delcenserie R, Yzet T, Ducroix JP. Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis. Pancreas 1996 ; 13 : 198-201.
22) Bassi C, Larvin M, Villatoro E. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev 2003 ; (4) : CD002941.
23) Spicak JHS, Cech P, Hoskovec D, et al. Antibiotic prophylaxis in severe acute pancreatitis : randomised multicenter prospective trial with meropenem. Pancreatology 2003 ; 3 : 220.
25) Spicak JHS, Cech P, Hoskovec D, et al. Antibiotic prophylaxis in large pancreatic necrosis : multicenter randomised trial with ciprofloxacin and metro nidazole or meropenem. Gatroenterology 2004 ; 126 (suppl 2) : A-229 (Abstract S1497)
28) Spicak J, Hubaczovai M, Antos F, et al. Antibiotics in the treatment of acute pancreatitis-findings from a randomized multi-centre prospective study (in Czech). Cesk Slov Gastroenterol Hepatol 2002 ; 56 : 183-9.
29) Spicak J, Hejtmainkovai S, Hubaczovai M, et al. Antibiotic prophylaxis of infectious complications of acute pancreatitis-the results of randomised study by meropenem (in Czech). Cesk Slov Gastroenterol Hepatol 2003 ; 57 : 222-7.
36) Barreda L, Targarona J, Milian W, et al. Is the prophylactic antibiotic therapy with Imipenem effective for patients with pancreatic necrosis? Acta Gastroenterol Latinoam 2009 ; 39 : 24-9.
39) Jiang K, Huang W, Yang XN, et al. Present and future of prophylactic antibiotics for severe acute pancreatitis. World J Gastroenterol 2012 ; 18 : 279-84.
40) Wittau M, Hohl K, Mayer J, et al. The weak evidence base for antibiotic prophylaxis in severe acute pancreatitis. Hepatogastroenterology 2008 ; 55 : 2233-7.
41) He YM, Lv XS, Ai ZL, et al. Prevention and therapy of fungal infection in severe acute pancreatitis : A prospective clinical study. World J Gastroenterol 2003 ; 9 : 2619-21.
44) 急性膵炎診療ガイドライン2010改訂出版委員会. 急性膵炎診療ガイドライン 2010, 第3版, 金原出版, 2009, 105-108.
P.282 掲載の参考文献
4) Hempel S, Newberry S, Ruelaz A, et al. Safety of probiotics to reduce risk and prevent or treat disease. Evidence report/technology assessment No. 200. AHRQPublication No. 11-E007. Rockville, MD : Agency for Healthcare Research and Quality ; 2011. http://www.ahrq.gov/clinic/tp/probiotictp.htm. Accessed October 27, 2012.
P.290 掲載の参考文献
13) Pongprasobchai S, Kridkratoke S, Nopmaneejumruslers C. Proton pump inhibitors for the prevention of stress-related mucosal disease in critically-ill patients : a meta-analysis. J Med Assoc Thai 2009 ; 92 : 632-7.
16) Powell H, Morgan M, Li SK, et al. Inhibition of gastric acid secretion in the intensive care unit after coronary artery bypass graft. A pilot control study of intravenous omeprazole by bolus and infusion, ranitidine and placebo. Theor Surg 1993 ; 8 : 125-30.
22) Kantorova I, Svoboda P, Scheer P, et al. Stress ulcer prophylaxis in critically ill patients : a randomized controlled trial. Hepatogastroenterology 2004 ; 51 : 757-61.
25) Solouki M, Marashian SM, Kouchak M, et al. Comparison between the preventive effects of ranitidine and omeprazole on upper gastrointestinal bleeding among ICU patients. Tanaffos 2009 ; 8 : 37-42.
34) Mostafa G, Sing RF, Matthews BD, et al. The economic benefit of practice guidelines for stress ulcer prophylaxis. Am Surg 2002 ; 68 : 146-50.
P.295 掲載の参考文献
P.308 掲載の参考文献
11) Bartlett RH, Dechert RE, Mault JR, et al. Measurement of metabolism in multiple organ failure. Surgery 1982 ; 92 : 771-9.
13) 寺島秀夫, 只野惣介, 大河内信弘. 必要エネルギー量の算出法と投与の実際 周術期を含め侵襲下におけるエネルギー投与に関する理論的考え方~既存のエネルギー投与量算定法からの脱却~. 静脈経腸栄養 2009 ; 24 : 1027-43.
33) ICU guideline : Gastric feeding. http://www.criticalcarenutrition.com/docs/tools/GastricFeeding.pdf Critical Care Nutrition. accessed 01/22/2013
P.318 掲載の参考文献
8) Rudiger A, Stotz M, Singer M. Cellular processes in sepsis. Swiss Med Wkly 2008 ; 138 : 629-34.
11) http://www.criticalcarenutrition.com/index.php?option=com_content&view=category&layout=blog&id=21&Itemid=10
P.328 掲載の参考文献
24) MacLaren R, Kiser TH, et al. Erythromycin vs metoclopramide for facilitating gastric emptying and tolerance to intragastric nutrition in critically ill patients. JPEN J Parenter Enteral Nutr 2008 ; 32 : 412-9.
25) Lu NF, Zheng RQ, Lin H, et al. Study of erythromycin and metoclopramide in treatment of feeding intolerance of critically ill patients in intensive care unit. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2010 ; 22 : 36-9.
35) Caliskan E, Turkoz A, Sener M, et al. A prospective randomized double-blind study to determine the effect of thoracic epidural neostigmine on postoperative ileus after abdominal aortic surgery. Anesth Analg 2008 ; 106 : 959-64.
42) Moerman I, Franck P, Camu F. Evaluation of methylnaltrexone for the reduction of postoperative vomiting and nausea incidences. Acta Anaesthesiol Belg 1995 ; 46 : 127-32.
44) Anissian L, Schwartz HW, Vincent K, et al. Subcutaneous methylnaltrexone for treatment of acute opioid-induced constipation : phase 2 study in rehabilitation after orthopedic surgery. J Hosp Med 2012 ; 7 : 67-72.
45) 高垣有作, 川崎貞男, 駒井宏好ほか. 腹部大動脈瘤術後腸管麻痺における大建中湯の腸管蠕動改善効果. 日臨外会誌 2000 ; 61 : 325-8.

内分泌, 代謝

P.335 掲載の参考文献
2) deGans J, van de Beek D, et al. Dexamethasone in adults with bacterial meningitis N Engl J Med 2001 ; 345 : 1727-33.
5) Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids for treating severe sepsis and septic shock. Cochrane Database Syst Rev 2010 : CD002243. Pub2.
9) CRASH trial collaborators. Final results of MRC CRASH, a randomized placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet 2005 ; 365 : 1957-9.
26) Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. New Engl J Med 1990 ; 322 : 1405-11.
28) Roquilly A, Mahe PJ, Seguin P, et al. Hydrocortisone therapy for patients with multiple trauma. The randomized controlled HYPOLYTE study. JAMA 2011 ; 305 : 1201-9.
38) ATS/ERS. American thoracic society/European respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Res Crit Care Med 2002 ; 165 : 277-304.
P.343 掲載の参考文献
5) Libby P, Akikawa M. Stabilization of atherosclerotic plaques : New mechanisms and clinical targets. Nat Med 2002 ; 8 : 1257-62.
9) Lier F, Schouten O, Poldermans D, et al. Statins in intensive care medicine : still too early to tell. Neth J Crit Care 2011 ; 15 : 137-42.
15) Ando H Takamura T, Ota T, et al. Cerivastatin improves survival of mice with Lipopolysaccharide-induced sepsis. J Pharmacol Exp Ther 2000 ; 294 : 1043-6.
29) Simvastatin and Severe Sepsis Trial (SIMSEPT), ISRCTN 92093279, EudraCT number 2005-003438-17.
30) Statins in Sepsis study, ACTRN 12607000028404.
31) Statins for the Early Treatment of Sepsis (SETS), ClinicalTrials. gov : NCT 00528580.
32) Study of Statin Therapy in the Treatment of Sepsis, ClinicalTrials. gov : NCT 00676897.
36) Statins for Acutely Injured Lungs from Sepsis (SAILS), Clinical Trials. gov : NCT00979121

感染

P.355 掲載の参考文献
2) 荒川宣親. 多剤耐性菌の現状について. 臨床検査 2012 ; 56 : 817-26.
3) Leclercq R, Canton R, Brown DF, et al. EUCAST expert rules in antimicrobial susceptivility testing. Clin Microbiol Infect, 2011.
5) 感染症法5類感染症, 42 薬剤耐性アシネトバクター感染症, 43 薬剤耐性緑膿菌感染症. http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou11/01.html
6) 松本哲哉. 多剤耐性緑膿菌 (MDRP). モダンメディア 2007 ; 53 : 74-9.
7) 松本哲哉, 山口惠三. 緑膿菌感染症. 日内会誌 2002 ; 91 : 2927-33.
8) 荒川宣親. 多剤耐性菌の現状について. 臨床検査 2012 ; 56 : 817-26.
10) Ishii Y, Ohno A, Taguchi H, et al. Cloning and sequence of the gene encording a cefotaximehydrolyzing class A β-lactamase isolated from Escherichia coli. Antimicrob Agnets Chemother 1995 ; 39 : 2269-75.
11) 木村由美子, 柳原克紀. ESBL産生菌 : 臨床検査 2012 ; 56 : 884-9.
12) 村谷哲郎. ESBL産生菌. Medical Technology 2011 ; 39 : 525-33.
13) Hanson ND, Sanders CC. Regulation of inducible AmpC β-lactamase expression among Enterobacteriaceae. Curr Pharm Des 1999 ; 5 : 881-94.
14) 岡本了一. AmpC産生グラム陰性桿菌. 小児科診療 2011 ; 74 : 1307-13.
15) 荒川宣親. メタロ-β-ラクタマーゼ (MBL) 産生グラム陰性桿菌. 小児科診療 2011 ; 74 : 1315-21.
16) Osano E, Arakawa Y, Wacharotayankun R, et al. Molecular characterization of an enterobacterial metallo β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 1994 ; 38 : 71-8.
17) 石井良和. 多剤耐性菌の検出方法. 臨床検査 2012 ; 56 : 827-35.
18) Arakawa Y, Shibata N, et al. Convenient test for screening metallo-β-lactamase-producing gram-negative bacteria by using thiol compounds. J Clin Microbiol 2000 ; 38 : 40-3.
19) Gudiol C, Tubau F, Calatayud L, et al. Bacteremia due to multidrug-resistant Gram-negative bacilli in cancer patients : risk factors, antibiotic therapy and outcomes, J Antimicro Chemother 2011 ; 66 : 657-63.
20) Nseir S, Blazejewski C, Lubret R, et al. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit. Clin Microbiol Infect 2011 ; 17 : 1201-8.
21) Depuydt P, Benoit D, Vogelaers D, et al. Systemic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia. Intensive Care Med 2008 ; 34 : 675-82.
22) Chen S-Y, Wu GH, Chang SC, et al. Bacteremia in previously hospitalized patients : prolonged effect from previous hospitalization and risk factors for antimicrobial-resistant bacrterial infections. Ann Emerg Med 2008 ; 51 : 639-46.
23) Nicasio AM, Eagye KJ, Nicolau DP, et al. Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia. J Crit Care 2010 ; 25 : 69-77.
24) Vogelaers D, De Bels D, Foret F, et al. Patterns of antimicrobial therapy in severe nosocomial infections : empiric choices, proportion of appropriate therapy, and adaptation rates -a multicentre, obsabational survey in critically ill patients. Int J Antimicrob Agents 2010 ; 35 : 375-81.
25) Rodriguez-Bano J, Navarro MD, Retamar P, et al. β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli : a post hoc analysis of prospective cohorts. Clin Infect Dis 2012 : 54 : 167-74.
26) Harbarth S, Garbino J, Pugin J, et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003 ; 115 : 529-35.
27) Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006 ; 34 : 1589-96.
28) Lepper PM, Grusa E, Reichi H, et al. Consumption of imipenem correlates with β-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2002 ; 46 : 2920-5.
29) Ohmagari N, Hannna H, Graviss L, et al. Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer 2005 ; 104 : 205-12.
30) McDonald JR, Friedman ND, Stout JE, et al. Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med 2005 ; 165 : 308-13.
31) Tateda K, Ishii Y, Matsumoto T, et al. 'Break-point Checkerboard Plate' for screening of appropriate antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa. Scand J Infect Dis 2006 ; 38 : 268-72.
32) 佐藤淳子. 多剤耐性菌に対する新規抗菌薬開発の動向. 臨床検査 2012 ; 56 : 904-7.
P.362 掲載の参考文献
1) Linscheid P, Seboek D, Nylen ES, et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells : a novel product of human adipose tissue. Endocrinology 2003 144 : 5578-84.
2) Schwarz S, Bertram M, Schwab S, et al. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med 2000 ; 28 : 1828-32.
3) Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis : clinical utility and limitations. Crit Care Med 2008 ; 36 : 941-52.
4) Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma : a systematic review and meta-analysis. Crit Care Med 2006 ; 34 : 1996-2003.
5) Aikawa N, Fujishima S, Endo S, et al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 2005 ; 11 : 152-9.
6) Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as mark ers of bacterial infection : a systematic review and meta-analysis. Clin Infect Dis 2004 15 ; 39 : 206-17.
7) Jensen JU, Heslet L, Jensen TH, et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006 ; 34 : 2596-602.
8) Karlsson S, Heikkinen M, Pettila V, et al. Predictive value of procalcitonin decrease in patients with severe sepsis : a prospective observational study. Crit Care 2010 ; 14 : R205.
32) Seligman R, Meisner M, Lisboa TC, et al. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 2006 ; 10 : R125.
33) Hillas G, Vassilakopoulos T, Plantza P, et al. C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia. Eur Respir J 2010 ; 35 : 805-11
34) Meisner M, Tschaikowsky K, Hutzler A, et al. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998 ; 24 : 680-4.
P.371 掲載の参考文献
7) National Collaborating Centre for Women's and Children's Health Commissioned by the National Institute for Health and Clinical Excellence. Surgical site infection prevention and treatment of surgical site infection, RCOG Press, 2008
9) Antimicrobial Prophylaxis for Surgery. Treat Guidel Med Lett 2009 ; 7 : 47-52.
10) WHO Guidelines for Safe Surgery 2009 Safe Surgery Saves Lives, WHO Press, 2009
11) Gilbert DN, Robert CM, Eliopoulos GM, et al. The Sanford guide to antimicrobial therapy 2012, Antimicrobial Therapy, Inc, 2012
22) Sisto T, Laurikka J, Tarkka MR. Ceftriaxone vs cefuroxime for infection prophylaxis in coronary bypass surgery. Scand J Thor Cardiovasc Surg 1994 ; 28 : 143-8.
23) Kriaras I, Michalopoulos A, Michalis A, et al. Antibiotic prophylaxis in cardiac surgery. J Cardiovasc Surg (Torino) 1997 ; 38 : 605-10.
P.377 掲載の参考文献
2) Muscedere JG, Martin CM, Heyland DK. The impact of ventilator-associated pneumonia on the Canadian health care system. J Crit Care 2008 ; 23 : 5-10.
17) Fagon JY, Chastre J, Wolff M et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 2000 ; 132 : 621-30.
20) Muscedere J, Dodek P, Keenan S, et al. Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia : diagnosis and treatment. J Crit Care 2008 ; 23 : 138-47.
P.385 掲載の参考文献
6) Chittoodan S, Breen D, O'Donnell BD, et al. Long versus short axis ultrasound guided approach for internal jugular vein cannulation : a prospective randomised controlled trial. Med Ultrason 2011 ; 13 : 21-5
24) Centers for Disease Control and Prevention (CDC). Vital signs : central line-associated blood stream infections-United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011 ; 60 : 243-8.
P.392 掲載の参考文献
6) Jang TN, Kuo BI, Shen SH, et al. Nosocomial gram-negative bacteremia in critically ill patients : epidemiologic characteristics and prognostic factors in 147 episodes. J Formos Med Assoc 1999 ; 98 : 465-73.
11) 日本版敗血症診療ガイドライン, 日本集中治療医学会sepsis registry委員会, 2012 http://www.jsicm.org/sepsisjapan2012.pdf
P.400 掲載の参考文献
1) 日本化学療法学会. 抗MRSA 薬の手引き (2008年改訂版) Accessed from http://www.chemotherapy.or.jp/guideline/koMRSA_1.pdf. On October 26, 2012.
2) Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011 ; 53 : 319.
4) Jacob JT, DiazGranados CA. High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections : a meta-analysis. Int Jr Infect Dis [doi : 10.1016/j.ijid.2012.08.005].
5) Mavros MN, Tansarli GS, Vardakas KZ, et al. Impact of vancomycin minimum inhibitory concentration on clinical outcomes of patients with vancomycin-susceptible Staphylococcus aureus infections : a meta-analysis and meta-regression. Int Jr Antimicrob Agents [doi : 10.1016/j.ijantimicag.2012.07.023].
27) 日本循環器学会. 感染性心内膜炎の予防と治療に関するガイドライン 2008年改訂版.
29) The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). Euro Heart J 2009 ; 30 : 2369-413.
P.410 掲載の参考文献
5) Bonilla FA. Secondary immunodeficiency due to miscellaneous causes. UpToDate 20. 1
6) Anaissie E. Overview of infections following hematopoietic cell transplantation. UpToDate 20. 1
8) Fishman JA. Infection in the solid organ transplant recipient. UpToDate 20. 1
13) Morse CG, High KP : Nutrition, immunity, and infection. In Mandell GL, Bennett JE, Dolin R. eds. Principles and Practice of Infectious Diseases, 7th ed. Philadelphia : Elsevier/Churchill Livingstone, 2010 : 151-159.
15) Azar A, Ballas ZK. Immune function in older adults. UpToDate 20. 1.
16) Ballow M. Secondary immune deficiency induced by drugs and biologics. UpToDate 20. 1.
17) Chatham WW. Glucocorticoid effects on the immune system. UpToDate 20. 1.
19) Ginzler E, Diamond H, Kaplan D, et al. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 1978 ; 21 : 37-44.
20) Wolfe F, Caplan L, Michaud K. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia : associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis Rheum 2006 ; 54 : 628-34.
21) Jick SS, Lieberman ES, Rahman MU, et al. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum 2006 ; 55 : 19-26.
22) Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000 ; 161 : S221-47.
23) Keiser PB, Nutman TB. Strongyloides stercoralis in the Immunocompromised Population. Clin Microbiol Rev 2004 ; 17 : 208-17.
24) Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Lancet 1994 ; 344 : 423-8.
25) Keenan RJ, Konishi H, Kawai A, et al. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg 1995 ; 60 : 580-5.
26) Segal BH, Sneller MC. Infectious complications of immunosuppressive therapy in patients with rheumatic diseases. Rheum Dis Clin North Am 1997 ; 23 : 219-37.
27) Kanik KS, Cash JM. Does methotrexate increase the risk of infection or malignancy? Rheum Dis Clin North Am 1997 ; 23 : 955-67.
28) Sullivan KM, Witherspoon RP, Storb R, et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease : prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 1988 ; 72 : 546-54.
29) Sarmiento JM, Dockrell DH, Schwab TR, et al. Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients. Clin Transplant 2000 ; 14 : 136-8.
30) A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation 1996 ; 61 : 1029-37.
31) Clowse MB, Stone JH. General toxicity of cyclophosphamide and chlorambucil in inflammatory diseases. UpToDate 20. 1.
34) Stone JH. Overview of biologic agents in the rheumatic diseases. UpToDate 20. 1.
35) Koo S, Marty FM, Baden LR. Infectious complications associated with immunomodulating biologic agents. Infect Dis Clin North Am 2010 ; 24 : 285-306.
36) Bia MJ, Andiman W, Gaudio K, et al. Effect of treatment with cyclosporine versus azathioprine on incidence and severity of cytomegalovirus infection posttransplantation. Transplantation 1985 ; 40 : 610-4.
37) Anolik JH, Friedberg JW, Zheng B, et al. B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny. Clin Immunol 2007 ; 122 : 139-45.
38) Cattaneo C, Spedini P, Casari S, et al. Delayed-onset peripheral blood cytopenia after rituximab : frequency and risk factor assessment in a consecutive series of 77 treatments. Leuk Lymphoma 2006 ; 47 : 1013-7.
39) Vidal L, Gafter-Gvili A, Leibovici L, et al. Rituximab maintenance for the treatment of patients with follicular lymphoma : systematic review and meta-analysis of randomized trials. J Natl Cancer Inst 2009 ; 101 : 248-55.
40) Aksoy S, Dizdar O, Hayran M, et al. Infectious complications of rituximab in patients with lymphoma during maintenance therapy : a systematic review and meta-analysis. Leuk Lymphoma 2009 ; 50 : 357-65.
41) Cabanillas F, Liboy I, Pavia O, et al. High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia : a frequently unrecognized and easily treatable complication. Ann Oncol 2006 ; 17 : 1424-7.
42) van Vollenhoven RF, Emery P, Bingham CO 3rd, et al. Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials. J Rheumatol 2010 ; 37 : 558-67.
43) Pescovitz MD, Torgerson TR, Ochs HD, et al. Type 1 Diabetes TrialNet Study Group. Effect of rituximab on human in vivo antibody immune responses. J Allergy Clin Immunol 2011 ; 128 : 1295-1302. e5.
44) Yeo W, Chan TC, Leung NW, et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 2009 ; 27 : 605-11.
45) Thistlethwaite JR Jr, Stuart JK, Mayes JT, et al. Complications and monitoring of OKT3 therapy. Am J Kidney Dis 1988 ; 11 : 112-9.
50) Stone JH. Tumor necrosis factor-alpha inhibitors : Risk of bacterial, viral, and fungal infections. UpTo-Date 20. 1.
53) Grijalva CG, Chen L, Delzell E, et al. Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA 2011 ; 306 : 2331-9.
56) Lane MA, McDonald JR, Zeringue AL, et al. TNF-α antagonist use and risk of hospitalization for infection in a national cohort of veterans with rheumatoid arthritis. Medicine (Baltimore) 2011 ; 90 : 139-45.
58) FDA Drug Safety Communication : drug labels for the tumor necrosis factor-alpha (TNFα) blockers now include warnings about infection with Legionella and Listeria bacteria. http://www.fda.gov/Drugs/DrugSafety/ucm270849.htm
61) Wallis RS. Tumor necrosis factor-alpha inhibitors and mycobacterial infections. UpToDate 20. 1.
63) Food and Drug Administration MedWatch. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124185.htm

血液・凝固

P.424 掲載の参考文献
7) Fujita S, Hirota S, Oda T, et al. Deep venous thrombosis after total hip or total knee arthroplasty in patients in Japan. Clin Orthop Relat Res 2000 ; (375) : 168-74.
12) White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 2009 ; 123 (suppl 4) : S11-7.
14) Sigel B, Edelstein AL, Felix WR, Jr., et al. Compression of the deep venous system of the lower leg during inactive recumbency. Arch Surg 1973 ; 106 : 38-43.
15) Agu O. Deep vein thrombosis : a risky business. Br J Theatre Nurs 1999 ; 9 : 290-1.
16) Walker L, Lamont S. Graduated compression stockings to prevent deep vein thrombosis. Nurs Stand 2008 ; 22 : 35-8.
17) Lawrence D, Kakkar VV. Graduated, static, external compression of the lower limb : a physiological assessment. Br J Surg 1980 ; 67 : 119-21.
18) Williams JT, Palfrey SM. Cost effectiveness and efficacy of below knee against above knee graduated compression stockings in the prevention of deep vein thrombosis. Phlebologie 1988 ; 41 : 809-11.
19) CLOTS (Clots in Legs Or sTockings after Stroke) Trial Collaboration. Thigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke : a randomized trial. Ann Intern Med 2010 ; 153 : 553-62.
20) Sparrow RA, Hardy JG, Fentem PH. Effect of 'antiembolism' compression hosiery on leg blood volume. Br J Surg 1995 ; 82 : 53-9.
21) Williams AM, Davies PR, Sweetnam DI, et al. Knee-length versus thigh-length graduated compression stockings in the prevention of deep vein thrombosis. Br J Surg 1996 ; 83 : 1553.
22) Hameed MF, Browse DJ, Immelman EJ, et al. Should knee-length replace thigh-length graduated compression stockings in the prevention of deep-vein thrombosis? S Afr J Surg 2002 ; 40 : 15-6.
23) Allan A, Williams JT, Bolton JP, et al. The use of graduated compression stockings in the prevention of postoperative deep vein thrombosis. Br J Surg 1983 ; 70 : 172-4.
24) Bergqvist D, Lindblad B. The thromboprophylactic effect of graded elastic compression stockings in combination with dextran 70. Arch Surg 1984 ; 119 : 1329-31.
25) Kalodiki EP, Hoppensteadt DA, Nicolaides AN, et al. Deep venous thrombosis prophylaxis with low molecular weight heparin and elastic compression in patients having total hip replacement. A randomised controlled trial. Int Angiol 1996 ; 15 : 162-8.
26) Turner GM, Cole SE, Brooks JH. The efficacy of graduated compression stockings in the prevention of deep vein thrombosis after major gynaecological surgery. Br J Obstet Gynaecol 1984 ; 91 : 588-91.
27) Turpie AG, Hirsh J, Gent M, et al. Prevention of deep vein thrombosis in potential neurosurgical patients. A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control. Arch Intern Med 1989 ; 149 : 679-81.
28) Wille-Jorgensen P, Thorup J, Fischer A, et al. Heparin with and without graded compression stockings in the prevention of thromboembolic complications of major abdominal surgery : a randomized trial. Br J Surg 1985 ; 72 : 579-81.
29) Dennis M, Sandercock PA, Reid J, et al. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1) : a multicentre, randomised controlled trial. Lancet 2009 ; 373 : 1958-65.
30) Kierkegaard A, Norgren L. Graduated compression stockings in the prevention of deep vein thrombosis in patients with acute myocardial infarction. Eur Heart J 1993 ; 14 : 1365-8.
31) Sachdeva A, Dalton M, Amaragiri SV, et al. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 2010 : CD001484.
32) Lensing AW, Hirsh J. 125 I-fibrinogen leg scanning : reassessment of its role for the diagnosis of venous thrombosis in post-operative patients. Thromb Haemost 1993 ; 69 : 2-7.
33) Chouhan VD, Comerota AJ, Sun L, et al. Inhibition of tissue factor pathway during intermittent pneumatic compression : A possible mechanism for antithrombotic effect. Arterioscler Thromb Vasc Biol 1999 ; 19 : 2812-7.
34) Kumar S, Walker MA. The effects of intermittent pneumatic compression on the arterial and venous system of the lower limb : a review. J Tissue Viability 2002 ; 12 : 58-60, 62-6.
35) Nollert MU, Diamond SL, McIntire LV. Hydrodynamic shear stress and mass transport modulation of endothelial cell metabolism. Biotechnol Bioeng 1991 ; 38 : 588-602.
36) Pedegana LR, Burgess EM, Moore AJ, et al. Prevention of thromboembolic disease by external pneumatic compression in patients undergoing total hip arthroplasty. Clin Orthop Relat Res 1977 ; (128) : 190-3.
37) Salzman EW, Sobel M, Lewis J, et al. Prevention of venous thromboembolism in unstable angina pectoris. N Engl J Med 1982 ; 306 : 991.
38) Sarmiento A, Goswami AD. Thromboembolic prophylaxis with use of aspirin, exercise, and graded elastic stockings or intermittent compression devices in patients managed with total hip arthroplasty. J Bone Joint Surg Am 1999 ; 81 : 339-46.
39) Ryan MG, Westrich GH, Potter HG, et al. Effect of mechanical compression on the prevalence of proximal deep venous thrombosis as assessed by magnetic resonance venography. J Bone Joint Surg Am 2002 ; 84-A : 1998-2004.
40) Silbersack Y, Taute BM, Hein W, et al. Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. J Bone Joint Surg Br 2004 ; 86 : 809-12.
41) Roderick P, Ferris G, Wilson K, et al. Towards evidence-based guidelines for the prevention of venous thromboembolism : systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Assess 2005 ; 9 : iii-iv, ix-x, 1-78.
42) Rasmussen A, Hansen PT, Lindholt J, et al. Venous thrombosis after abdominal surgery. A comparison between subcutaneous heparin and antithrombotic stockings, or both. J Med 1988 ; 19 : 193-201.
43) Knudson MM, Collins JA, Goodman SB, et al. Thromboembolism following multiple trauma. J Trauma 1992 ; 32 : 2-11.
44) Coe NP, Collins RE, Klein LA, et al. Prevention of deep vein thrombosis in urological patients : a controlled, randomized trial of low-dose heparin and external pneumatic compression boots. Surgery 1978 ; 83 : 230-4.
45) Nicolaides AN, Fernandes e Fernandes J, Pollock AV. Intermittent sequential pneumatic compression of the legs in the prevention of venous stasis and postoperative deep venous thrombosis. Surgery 1980 ; 87 : 69-76.
46) Clarke-Pearson DL, Synan IS, Dodge R, et al. A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery. Am J Obstet Gynecol 1993 ; 168 : 1146-53 ; discussion 1153-44.
47) Santori FS, Vitullo A, Stopponi M, et al. Prophylaxis against deep-vein thrombosis in total hip replacement. Comparison of heparin and foot impulse pump. J Bone Joint Surg Br 1994 ; 76 : 579-83.
48) Norgren L, Toksvig-Larsen S, Magyar G, et al. Prevention of deep vein thrombosis in knee arthroplasty. Preliminary results from a randomized controlled study of low molecular weight heparin vs foot pump compression. Int Angiol 1998 ; 17 : 93-6.
49) Kosir MA, Schmittinger L, Barno-Winarski L, et al. Prospective double-arm study of fibrinolysis in surgical patients. J Surg Res 1998 ; 74 : 96-101.
50) Blanchard J, Meuwly JY, Leyvraz PF, et al. Prevention of deep-vein thrombosis after total knee replacement. Randomised comparison between a low-molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump system. J Bone Joint Surg Br 1999 ; 81 : 654-9.
51) Maxwell GL, Synan I, Dodge R, et al. Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery : a randomized trial. Obstet Gynecol 2001 ; 98 : 989-95.
52) Pitto RP, Hamer H, Heiss-Dunlop W, et al. Mechanical prophylaxis of deep-vein thrombosis after total hip replacement a randomised clinical trial. J Bone Joint Surg Br 2004 ; 86 : 639-42.
53) Ginzburg E, Cohn SM, Lopez J, et al. Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma. Br J Surg 2003 ; 90 : 1338-44.
54) Kurtoglu M, Yanar H, Bilsel Y, et al. Venous thromboembolism prophylaxis after head and spinal trauma : intermittent pneumatic compression devices versus low molecular weight heparin. World J Surg 2004 ; 28 : 807-11.
55) Camporese G, Bernardi E, Prandoni P, et al. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy : a randomized trial. Ann Intern Med 2008 ; 149 : 73-82.
56) Bradley JG, Krugener GH, Jager HJ. The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. J Arthroplasty 1993 ; 8 : 57-61.
57) Eisele R, Kinzl L, Koelsch T. Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. J Bone Joint Surg Am 2007 ; 89 : 1050-6.
58) Ramos R, Salem BI, De Pawlikowski MP, et al. The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest 1996 ; 109 : 82-5.
59) Woolson ST, Watt JM. Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. J Bone Joint Surg Am 1991 ; 73 : 507-12.
60) Kakkos SK, Caprini JA, Geroulakos G, et al. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thrombo-embolism in high-risk patients. Eur J Vasc Endovasc Surg 2009 ; 37 : 364-5.
61) Stein PD, Kayali F, Olson RE. Twenty-one-year trends in the use of inferior vena cava filters. Arch Intern Med 2004 ; 164 : 1541-5.
62) Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease : Antithrombotic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 ; 141 : e419S-94S.
63) Stein PD, Matta F, Hull RD. Increasing use of vena cava filters for prevention of pulmonary embolism. Am J Med 2011 ; 124 : 655-61.
64) Ozturk C, Ganiyusufoglu K, Alanay A, et al. Efficacy of prophylactic placement of inferior vena cava filter in patients undergoing spinal surgery. Spine (Phila Pa 1976) 2010 ; 35 : 1893-6.
65) Fullen WD, Miller EH, Steele WF, et al. Prophylactic vena caval interruption in hip fractures. J Trauma 1973 ; 13 : 403-10.
66) Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998 ; 338 : 409-15.
67) PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism : the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 2005 ; 112 : 416-22.
68) Lacut K, Bressollette L, Le Gal G, et al. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 2005 ; 65 : 865-9.
69) Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999 ; 341 : 793-800.
70) Leizorovicz A, Cohen AT, Turpie AG, et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004 ; 110 : 874-9.
71) Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients : randomised placebo controlled trial. BMJ 2006 ; 332 : 325-29.
72) Kakkar AK, Cimminiello C, Goldhaber SZ, et al. Low-molecular-weight heparin and mortality in acutely ill medical patients. N Engl J Med 2011 ; 365 : 2463-72.
73) Moores CL. Just do it ! : meeting patient safety goals in VTE prevention. Chest 2012 ; 141 : 578-80.
74) Kakkos SK, Caprini JA, Geroulakos G, et al. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev 2008 : CD005258.
75) Richard H, 3rd, Widlus DM, Scalea TM. Inferior vena cava filters in trauma : balancing pulmonary embolism prevention with the risk of deep venous thrombosis. J Trauma 2010 ; 69 : 1003 ; author reply 1003-4.
76) Rogers SO, Jr., Kilaru RK, Hosokawa P, et al. Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery : results from the patient safety in surgery study. J Am Coll Surg 2007 ; 204 : 1211-21.
77) Bahl V, Hu HM, Henke PK, et al. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg 2010 ; 251 : 344-50.
P.439 掲載の参考文献
1) Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998 : an analysis using multiple-cause mortality data. Arch Intern Med 2003 ; 163 : 1711-7.
2) Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism : clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999 ; 353 : 1386-9.
3) Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992 ; 326 : 1240-5.
4) Calvo-Romero JM, Perez-Miranda M, Bureo-Dacal P. Wheezing in patients with acute pulmonary embolism with and without previous cardiopulmonary disease. European journal of emergency medicine : official journal of the European Society for Emergency Medicine 2003 ; 10 : 288-9.
5) Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism : increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000 ; 83 : 416-20.
6) Wicki J, Perneger TV, Junod AF, et al. Assessing clinical probability of pulmonary embolism in the emergency ward : a simple score. Arch Intern Med 2001 ; 161 : 92-7.
7) Le Gal G, Righini M, Roy PM, et al. Prediction of pulmonary embolism in the emergency department : the revised Geneva score. Ann Intern Med 2006 ; 144 : 165-71.
8) Chagnon I, Bounameaux H, Aujesky D, et al. Comparison of two clinical prediction rules and implicit assessment among patients with suspected pulmonary embolism. Am J Med 2002 ; 113 : 269-75.
9) Kline JA, Runyon MS, Webb WB, et al. Comparison of the Unstructured Clinician Estimate of Pretest Probability for Pulmonary Embolism to the Canadian Score and the Charlotte Rule : A Prospective Observational Study. Academic Emergency Medicine 2005 ; 12 : 587-93.
10) Wolf SJ, McCubbin TR, Feldhaus KM, et al. Prospective validation of Wells Criteria in the evaluation of patients with suspected pulmonary embolism. Ann Emerg Med 2004 ; 44 : 503-10.
11) Rodger MA, Maser E, Stiell I, et al. The interobserver reliability of pretest probability assessment in patients with suspected pulmonary embolism. Thrombosis Research 2005 ; 116 : 101-7.
12) Douma RA, Mos ICM, Erkens PMG, et al. Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism : a prospective cohort study. Ann Intern Med 2011 ; 154 : 709-18.
13) Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008 ; 29 : 2276-315.
14) Stein PD, Hull RD, Patel KC, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism : a systematic review. Ann Intern Med 2004 ; 140 : 589-602.
15) Rodger MA, Carrier M, Jones GN, et al. Diagnostic value of arterial blood gas measurement in suspected pulmonary embolism. Am J Respir Criti Care Med 2000 ; 162 : 2105-8.
16) Stein PD, Terrin ML, Hales CA, et al. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest 1991 ; 100 : 598-603.
17) Thames MD, Alpert JS, Dalen JE. Syncope in patients with pulmonary embolism. JAMA 1977 ; 238 : 2509-11.
18) Geibel A. Prognostic value of the ECG on admission in patients with acute major pulmonary embolism. Europ Respirat J 2005 ; 25 : 843-8.
19) Worsley DF, Alavi A, Aronchick JM, et al. Chest radiographic findings in patients with acute pulmonary embolism : observations from the PIOPED Study. Radiology 1993 ; 189 : 133-6.
20) Stein PD, Alavi A, Gottschalk A, et al. Usefulness of noninvasive diagnostic tools for diagnosis of acute pulmonary embolism in patients with a normal chest radiograph. Am J Cardiol 1991 ; 67 : 1117-20.
21) Miniati M, Monti S, Pratali L, et al. Value of transthoracic echocardiography in the diagnosis of pulmonary embolism : results of a prospective study in unselected patients. Am J Med 2001 ; 110 : 528-35.
22) Kurzyna M, Torbicki A, Pruszczyk P, et al. Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism. Am J Cardiol 2002 ; 90 : 507-11.
23) Kucher N, Luder CM, Dornhofer T, et al. Novel management strategy for patients with suspected pulmonary embolism. Eur Heart J 2003 ; 24 : 366-76.
24) Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease : Antithrombotic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 ; 141 : e419S-94S.
25) Perrier A, Bounameaux H. Ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med 1998 ; 128 : 243 ; author reply 4-5.
26) Kearon C, Ginsberg JS, Hirsh J. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med 1998 ; 129 : 1044-9.
27) Bates SM, Jaeschke R, Stevens SM, et al. Diagnosis of DVT : Antithrombotic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 ; 141 : e351S-418S.
28) Mullins MD, Becker DM, Hagspiel KD, et al. The role of spiral volumetric computed tomography in the diagnosis of pulmonary embolism. Arch Intern Med 2000 ; 160 : 293-8.
29) Rathbun SW, Raskob GE, Whitsett TL. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism : a systematic review. Ann Intern Med 2000 ; 132 : 227-32.
30) Van Strijen MJL, De Monye W, Kieft GJ, et al. Accuracy of single-detector spiral CT in the diagnosis of pulmonary embolism : a prospective multicenter cohort study of consecutive patients with abnormal perfusion scintigraphy. J Thromb Haemost 2005 ; 3 : 17-25.
31) Perrier A, Howarth N, Didier D, et al. Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism. Ann Intern Med 2001 ; 135 : 88-97.
32) Musset D, Parent F, Meyer G, et al. Diagnostic strategy for patients with suspected pulmonary embolism : a prospective multicentre outcome study. Lancet 2002 ; 360 : 1914-20.
33) Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. New Engl J Med 2006 ; 354 : 2317-27.
34) van Belle A, Buller HR, Huisman MV, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006 ; 295 : 172-9.
35) Anderson DR, Kahn SR, Rodger MA, et al. Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism : a randomized controlled trial. JAMA 2007 ; 298 : 2743-53.
36) Righini M, Le Gal G, Aujesky D, et al. Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg : a randomised non-inferiority trial. Lancet 2008 ; 371 : 1343-52.
37) Courtney DM, Miller C, Smithline H, et al. Prospective multicenter assessment of interobserver agreement for radiologist interpretation of multidetector computerized tomographic angiography for pulmonary embolism. J Thromb Haemost 2010 ; 8 : 533-9.
38) Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED Investigators. JAMA 1990 ; 263 : 2753-9.
39) Wolfe MW, Skibo LK, Goldhaber SZ. Pulmonary embolic disease : diagnosis, pathophysiologic aspects, and treatment with thrombolytic therapy. Curr Probl Cardiol 1993 ; 18 : 587-633.
40) Stein PD, Henry JW, Gottschalk A. Reassessment of pulmonary angiography for the diagnosis of pulmonary embolism : relation of interpreter agreement to the order of the involved pulmonary arterial branch. Radiology 1999 ; 210 : 689-91.
41) Kuiper JW, Geleijns J, Matheijssen NA, et al. Radiation exposure of multi-row detector spiral computed tomography of the pulmonary arteries : comparison with digital subtraction pulmonary angiography. Eur Radiol 2003 ; 13 : 1496-500.
42) Stein PD, Chenevert TL, Fowler SE, et al. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism : a multicenter prospective study (PIOPED III). Ann Intern Med 2010 ; 152 : 434-43, W142-3.
43) Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients : Antithrombotic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 ; 141 : e195S-226S.
45) Brotman DJ, Segal JB, Jani JT, et al. Limitations of D-dimer testing in unselected inpatients with suspected venous thromboembolism. Am J Med 2003 ; 114 : 276-82.
46) Winkler BE, Schuetz W, Froeba G, et al. N-terminal prohormone of brain natriuretic peptide : a useful tool for the detection of acute pulmonary artery embolism in post-surgical patients. Br J Anaesth 2012 ; 109 : 907-10.
47) Kollef MH, Zahid M, Eisenberg PR. Predictive value of a rapid semiquantitative D-dimer assay in critically ill patients with suspected venous thromboembolic disease. Crit Care Med 2000 ; 28 : 414-20.
48) Wittram C, Maher MM, Yoo AJ, et al. CT angiography of pulmonary embolism : diagnostic criteria and causes of misdiagnosis. Radiographics 2004 ; 24 : 1219-38.
49) Ravenel JG, Northam MC, Nguyen SA. Negative predictive value of computed tomography pulmonary angiography with indirect computed tomography venography in intensive care unit patients. J Comput Assist Tomogr 2009 ; 33 : 739-42.
50) Grigorakos L, Sotiriou E, Myrianthefs P, et al. Approach to patients with pulmonary embolism in a surgical intensive care unit. Hepatogastroenterology 2008 ; 55 : 887-90.
51) Kelly AM, Patel S, Carlos RC, et al. Multidetector row CT pulmonary angiography and indirect venography for the diagnosis of venous thromboembolic disease in intensive care unit patients. Acad Radiol 2006 ; 13 : 486-95.
52) Velmahos GC, Vassiliu P, Wilcox A, et al. Spiral computed tomography for the diagnosis of pulmonary embolism in critically ill surgical patients : a comparison with pulmonary angiography. Arch Surg 2001 ; 136 : 505-11.
53) Jolliet P, Slosman DO, Ricou B, et al. Pulmonary scintigraphy at the bedside in intensive care patients with suspected pulmonary embolism. Intensive Care Med 1995 ; 21 : 723-8.
54) Stawicki SP, Seamon MJ, Kim PK, et al. Transthoracic echocardiography for pulmonary embolism in the ICU : finding the "right" findings. J Am Coll Surg 2008 ; 206 : 42-7.
55) Velmahos GC, Brown CV, Demetriades D. The (absence of a) role of venous duplex scan in the diagnosis of pulmonary embolism after severe trauma. Am Surg 2006 ; 72 : 7-10.
56) Cook D, McMullin J, Hodder R, et al. Prevention and diagnosis of venous thromboembolism in critically ill patients : a Canadian survey. Crit Care 2001 ; 5 : 336-42.
57) Vieillard-Baron A, Qanadli SD, Antakly Y, et al. Transesophageal echocardiography for the diagnosis of pulmonary embolism with acute cor pulmonale : a comparison with radiological procedures. Intensive Care Med 1998 ; 24 : 429-33.
58) Brathwaite CE, O'Malley KF, Ross SE, et al. Continuous pulse oximetry and the diagnosis of pulmonary embolism in critically ill trauma patients. J Trauma 1992 ; 33 : 528-30 ; discussion 30-1.
P.448 掲載の参考文献
1) Takei T, Amin NA, Schmid G, et al. Progress in global blood safety for HIV. J Acquir Immune Defic Syndr 2009 ; 52 (suppl 2) : S127-31.
2) Practice Guidelines for blood component therapy : A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996 ; 84 : 732-47.
3) Napolitano LM, Kurek S, Luchette FA, et al. Clinical practice guideline : red blood cell transfusion in adult trauma and critical care. Crit Care Med 2009 ; 37 : 3124-57.
4) Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion : a clinical practice guideline from the AABB*. Ann Intern Med 2012 ; 157 : 49-58.
5) Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012 ; 4 : CD002042.
6) Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011 ; 365 : 2453-62.
7) Lacroix J, Hebert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007 ; 356 : 1609-19.
8) Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999 ; 340 : 409-17.
9) Hayden SJ, Albert TJ, Watkins TR, et al. Anemia in critical illness : insights into etiology, consequences, and management. Am J Respir Crit Care Med 2012 ; 185 : 1049-57.
10) Klein HG, Anstee DJ. Mollison's Blood Transfusion in Clinical Medicine. Wiley-Blackwell, 2012.
11) Offner PJ. Age of blood : does it make a difference? Crit Care 2004 ; 8 (suppl 2) : S24-6.
12) Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008 ; 358 : 1229-39.
13) Dzik W. Fresh blood for everyone? Balancing availability and quality of stored RBCs. Transfus Med 2008 ; 18 : 260-5.
14) Pavenski K, Saidenberg E, Lavoie M, et al. Red blood cell storage lesions and related transfusion issues : a Canadian Blood Services research and development symposium. 2012, 68-84.
15) Blajchman MA, Glynn SA, Josephson CD, et al, State-of-the Science Symposium Transfusion Medicine Committee. Clinical trial opportunities in Transfusion Medicine : proceedings of a National Heart, Lung, and Blood Institute State-of-the-Science Symposium. 2010, 259-85.
16) Zubair AC. Clinical impact of blood storage lesions. Am J Hematol 2010 ; 85 : 117-22.
17) Zimring JC, Welniak L, Semple JW, et al. Current problems and future directions of transfusion-induced alloimmunization : summary of an NHLBI working group. 2011, 435-41.
18) Yap C-H, Lau L, Krishnaswamy M, et al. Age of transfused red cells and early outcomes after cardiac surgery. Ann Thorac Surg 2008 ; 86 : 554-9.
19) Edgren G, Kamper-Jorgensen M, Eloranta S, et al. Duration of red blood cell storage and survival of transfused patients (CME). Transfusion 2010 ; 50 : 1185-95.
20) Wang D, Sun J, Solomon SB, et al. Transfusion of older stored blood and risk of death : a meta-analysis. Transfusion 2012 ; 52 : 1184-95.
21) Flegel WA. Fresh blood for transfusion : how old is too old for red blood cell units? Blood Transfus 2012 ; 10 : 247-51.
22) Kor DJ, Kashyap R, Weiskopf RB, et al. Fresh red blood cell transfusion and short-term pulmonary, immunologic, and coagulation status : a randomized clinical trial. Am J Respir Crit Care Med 2012 ; 185 : 842-50.
23) Middelburg RA, Borkent-Raven BA, Borkent B, et al. Storage time of blood products and transfusion-related acute lung injury. Transfusion 2012 ; 52 : 658-67.
24) Fergusson DA, Hebert P, Hogan DL, et al. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants : the ARIPI randomized trial. JAMA 2012 ; 308 : 1443-51.
25) Gauvin F, Spinella PC, Lacroix J, et al. Association between length of storage of transfused red blood cells and multiple organ dysfunction syndrome in pediatric intensive care patients. Transfusion 2010 ; 50 : 1902-13.
26) Lacroix J, Hebert P, Fergusson D, et al. The Age of Blood Evaluation (ABLE) randomized controlled trial : study design. Transfus Med Rev 2011 ; 25 : 197-205.
27) Steiner ME, Assmann SF, Levy JH, et al. Addressing the question of the effect of RBC storage on clinical outcomes : the Red Cell Storage Duration Study (RECESS) (Section 7). Transfus Apher Sci 2010 ; 43 : 107-16.
28) Heddle NM, Cook RJ, Arnold DM, et al. The effect of blood storage duration on in-hospital mortality : a randomized controlled pilot feasibility trial. Transfusion 2012 ; 52 : 1203-12.
29) Aubron C, Syres G, Nichol A, et al. A pilot feasibility trial of allocation of freshest available red blood cells versus standard care in critically ill patients. Transfusion 2012 ; 52 : 1196-202.
30) Rogiers P, Zhang H, Leeman M, et al. Erythropoietin response is blunted in critically ill patients. Intensive Care Med 1997 ; 23 : 159-62.
31) van Iperen CE, Gaillard CA, Kraaijenhagen RJ, et al. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000 ; 28 : 2773-8.
32) Zarychanski R, Turgeon AF, McIntyre L, et al. Erythropoietin-receptor agonists in critically ill patients : a meta-analysis of randomized controlled trials. CMAJ 2007 ; 177 : 725-34.
33) Luchette FA, Pasquale MD, Fabian TC, et al. A randomized, double-blind, placebo-controlled study to assess the effect of recombinant human erythropoietin on functional outcomes in anemic, critically ill, trauma subjects : the Long Term Trauma Outcomes Study. Am J Surg 2012 ; 203 : 508-16.
34) Piagnerelli M, Vincent J-L. The use of erythropoiesis-stimulating agents in the intensive care unit. Crit Care Clin 2012 ; 28 : 345-62-v.
35) Corwin HL, Gettinger A, Fabian TC, et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 2007 ; 357 : 965-76.
36) Corwin HL, Gettinger A, Pearl RG, et al. Efficacy of recombinant human erythropoietin in critically ill patients : a randomized controlled trial. JAMA 2002 ; 288 : 2827-35.
37) Corwin HL, Gettinger A, Rodriguez RM, et al. Efficacy of recombinant human erythropoietin in the critically ill patient : a randomized, double-blind, placebo-controlled trial. Crit Care Med 1999 ; 27 : 2346-50.
38) Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998 ; 339 : 584-90.
39) Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006 ; 355 : 2085-98.
40) Drueke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006 ; 355 : 2071-84.
41) Pfeffer MA, Burdmann EA, Chen C-Y, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009 ; 361 : 2019-32.
42) Berns JS. Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients? Curr Opin Nephrol Hypertens 2010 ; 19 : 567-72.
43) Hajjar LA, Vincent J-L, Galas FRBG, et al. Transfusion requirements after cardiac surgery : the TRACS randomized controlled trial. JAMA 2010 ; 304 : 1559-67.
P.457 掲載の参考文献
1) Estcourt LJ, Stanworth SJ, Murphy MF. Platelet transfusions for patients with haematological malignancies : who needs them? Br J Haematol 2011 ; 154 : 425-40.
2) Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981 ; 47 : 207-14.
3) Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med 1997 ; 337 : 1870-5.
4) Wandt H, Schaefer-Eckart K, Wendelin K, et al. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies : an open-label, multicentre, randomised study. Lancet 2012 ; 380 : 1309-16.
5) Gaydos LA, Freireich EJ, Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med 1962 ; 266 : 905-9.
6) Slichter SJ, Harker LA. Thrombocytopenia : mechanisms and management of defects in platelet production. Clin Haematol 1978 ; 7 : 523-39.
7) Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia : evidence for a fixed platelet requirement. Blood 1985 ; 66 : 1105-9.
8) Heddle NM, Cook RJ, Sigouin C, et al. A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia. Transfusion 2006 ; 46 : 903-11.
9) Slichter SJ, Kaufman RM, Assmann SF, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010 ; 362 : 600-13.
10) Webert K, Cook RJ, Sigouin CS, et al. The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia. Haematologica 2006 ; 91 : 1530-7.
11) Ho-Tin-Noe B, Goerge T, Cifuni SM, et al. Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res 2008 ; 68 : 6851-8.
12) Friedmann AM, Sengul H, Lehmann H, et al. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. Transfus Med Rev 2002 ; 16 : 34-45.
13) Heddle NM, Cook RJ, Webert KE, et al. Biomedical Excellence for Safer Transfusion Working Party of the International Society for Blood Transfusion. Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies. Transfusion 2003 ; 43 : 742-52.
14) Schiffer CA, Anderson KC, Bennett CL, et al. Platelet transfusion for patients with cancer : clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001 ; 19 : 1519-38.
15) British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol 2003 ; 122 : 10-23.
16) Slichter SJ. Evidence-based platelet transfusion guidelines. Hematology Am Soc Hematol Educ Program 2007 ; 172-8.
17) Liumbruno G, Bennardello F, Lattanzio A, et al. Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Work Group. Recommendations for the transfusion of plasma and platelets. Blood Transfus 2009 ; 7 : 132-50.
18) Wandt H, Schaefer-Eckart K, Frank M, et al. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2006 ; 37 : 387-92.
19) Estcourt L, Stanworth S, Doree C, et al. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev 2012 ; 5 : CD004269.
20) Stanworth SJ, Dyer C, Choo L, et al. Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions. Transfus Med Rev 2010 ; 24 : 163-71.
21) Heckman KD, Weiner GJ, Davis CS, et al. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia : 10,000/microL versus 20,000/microL. J Clin Oncol 1997 ; 15 : 1143-9.
22) Zumberg MS, del Rosario MLU, Nejame CF, et al. A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients : 10,000/L versus 20,000/microL trigger. Biol Blood Marrow Transplant 2002 ; 8 : 569-76.
23) Diedrich B, Remberger M, Shanwell A, et al. A prospective randomized trial of a prophylactic platelet transfusion trigger of 10×10 (9) per L versus 30×10 (9) per L in allogeneic hematopoietic progenitor cell transplant recipients. Transfusion 2005 ; 45 : 1064-72.
24) Hedner U, Lee CA. First 20 years with recombinant FVIIa (NovoSeven). Haemophilia 2011 ; 17 : e172-82.
25) Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med 2007 ; 356 : 2301-11.
26) Logan AC, Yank V, Stafford RS. Off-label use of recombinant factor VIIa in U. S. hospitals : analysis of hospital records. Ann. Intern Med 2011 ; 154 : 516-22.
27) Logan AC, Goodnough LT. Recombinant factor VIIa : an assessment of evidence regarding its efficacy and safety in the off-label setting. Hematology Am Soc Hematol Educ Program 2010 ; 2010 : 153-9.
28) Hauser CJ, Boffard K, Dutton R, et al. Results of the CONTROL trial : efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma 2010 ; 69 : 489-500.
29) Gill R, Herbertson M, Vuylsteke A, et al. Safety and efficacy of recombinant activated factor VII : a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 2009 ; 120 : 21-7.
30) Al-Shahi Salman R. Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage. Cochrane Database Syst Rev 2009 ; (4) : CD005951.
31) Marti-Carvajal AJ, Karakitsiou D-E, Salanti G. Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases. Cochrane Database Syst Rev 2012 ; 3 : CD004887.
32) Gurusamy KS, Pissanou T, Pikhart H, et al. Methods to decrease blood loss and transfusion requirements for liver transplantation. Cochrane Database Syst Rev 2011 ; (12) : CD009052.
33) Pihusch M, Bacigalupo A, Szer J, et al. Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation. J Thromb Haemost 2005 ; 3 : 1935-44.
34) Huber AW, Raio L, Alberio L, et al. Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage : single center study. J Perinat Med 2011 ; 40 : 43-9.
35) Levi M, Levy JH, Andersen HF, et al. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010 ; 363 : 1791-800.
36) Simpson E, Lin Y, Stanworth S, et al. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2012 ; 3 : CD005011.
37) Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008 ; 358 : 2127-37.
38) Lodge JPA, Jonas S, Jones RM, et al. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl 2005 ; 11 : 973-9.
39) Sachs B, Delacy D, Green J, et al. Recombinant activated factor VII in spinal surgery : a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial. Spine 2007 ; 32 : 2285-93.
40) Goodnough LT, Lublin DM, Zhang L, et al. Transfusion medicine service policies for recombinant factor VIIa administration. Transfusion 2004 ; 44 : 1325-31.
41) Despotis G, Avidan M, Lublin DM. Off-label use of recombinant factor VIIA concentrates after cardiac surgery. Ann Thorac Surg 2005 ; 80 : 3-5.
42) Levy JH, Sniecinski RM. Prohemostatic treatment in cardiac surgery. Semin Thromb Hemost 2012 ; 38 : 237-43.
43) Sniecinski RM, Levy JH. Bleeding and management of coagulopathy. J Thorac Cardiovasc Surg 2011 ; 142 : 662-7.
44) Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008 ; 358 : 2319-31.
45) Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011 ; (3) : CD001886.
46) CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) : a randomised, placebo-controlled trial. Lancet 2010 ; 376 : 23-32.
47) Martin K, Wiesner G, Breuer T, et al. The risks of aprotinin and tranexamic acid in cardiac surgery : a one-year follow-up of 1188 consecutive patients. Anesth Analg 2008 ; 107 : 1783-90.
48) Murkin JM, Falter F, Granton J, et al. High-dose tranexamic Acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010 ; 110 : 350-3.
49) Sander M, Spies CD, Martiny V, et al. Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures : a retrospective analysis. Crit Care 2010 ; 14 : R148.
50) Montes FR, Pardo DF, Carreno M, et al. Risk factors associated with postoperative seizures in patients undergoing cardiac surgery who received tranexamic acid : a case-control study. Ann Card Anaesth 2012 ; 15 : 6-12.
51) Kalavrouziotis D, Voisine P, Mohammadi S, et al. High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg 2012 ; 93 : 148-54.
52) Furtmuller R, Schlag MG, Berger M, et al. Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid (A) receptor antagonistic effect. J Pharmacol Exp Ther 2002 ; 301 : 168-73.
53) Schlag MG, Hopf R, Redl H. Convulsive seizures following subdural application of fibrin sealant containing tranexamic acid in a rat model. Neurosurgery 2000 ; 47 : 1463-7.
54) Yamaura A, Nakamura T, Makino H, et al. Cerebral complication of antifibrinolytic therapy in the treatment of ruptured intracranial aneurysm. Animal experiment and a review of literature. Eur Neurol 1980 ; 19 : 77-84.
55) Yeh H-M, Lau H-P, Lin P-L, et al. Convulsions and refractory ventricular fibrillation after intrathecal injection of a massive dose of tranexamic acid. Anesthesiology 2003 ; 98 : 270-2.
56) Mohseni K, Jafari A, Nobahar MR, et al. Polymyoclonus seizure resulting from accidental injection of tranexamic acid in spinal anesthesia. Anesth Analg 2009 ; 108 : 1984-6.

外傷・熱傷

P.462 掲載の参考文献
1) American College of Surgeons Advanced Trauma Life Support(R) student course manual 8th edition. 2008.
2) 日本外傷学会・日本救急医学会. 外傷初期診療ガイドライン JATEC : 2008.
3) Shires T, Cold D, Carrico J, et al. Fluid Therapy in Hemorrhagic Shock. Arch Surg 1964 ; 88 : 688-93.
4) Gow PJ, Chapman RW. Modern management of oesophageal varices. Postgrad Med J 2001 ; 77 : 75-81.
5) Antonello M. Diagnosis, Screening and Treatment of Abdominal, Thoracoabdominal and Thoracic Aortic Aneurysms 2011 ; 195-214.
6) Gruen RL, Brohi K, Schreiber M, et al. Haemorrhage control in severely injured patients. Lancet 2012 ; 380 : 1099-108.
7) Duke MD, Guidry C, Guice J, et al. Restrictive fluid resuscitation in combination with damage control resuscitation : time for adaptation. J Trauma Acute Care Surg 2012 ; 73 : 674-8.
8) Stern SA, Dronen SC, Birrer P, et al. Effect of blood pressure on hemorrhage volume and survival in a near-fatal hemorrhage model incorporating a vascular injury. Ann Emerg Med 1993 ; 22 : 155-63.
9) Capone AC, Safar P, Stezoski W, et al. Improved outcome with fluid restriction in treatment of uncontrolled hemorrhagic shock. J Am Coll Surg 1995 ; 180 : 49-56.
10) Krausz MM, Bashenko Y, Hirsh M. Crystalloid and colloid resuscitation of uncontrolled hemorrhagic shock following massive splenic injury. Shock 2001 ; 16 : 383-8.
11) Mapstone J, Roberts I, Evans P. Fluid resuscitation strategies : a systematic review of animal trials. J Trauma 2003 ; 55 : 571-89.
12) Bickell WH, Wall MJ Jr, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hy potensive patients with penetrating torso injuries. N Engl J Med 1994 ; 331 : 1105-9.
13) Turner J, Nicholl J, Webber L, et al. A randomised controlled trial of prehospital intravenous fluid replacement therapy in serious trauma. Health Technol Assess 2000 ; 4 : 1-57.
14) Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitation during active hemorrhage : impact on in-hospital mortality. J Trauma 2002 ; 52 : 1141-6.
15) Alsawadi, A. The clinical effectiveness of permissive hypotension in blunt abdominal trauma with hemorrhagic shock but without head or spine injuries or burns : a systematic review. Open Access Emergency Medicine 2012 ; 4 : 21-9.
16) Morrison CA, Carrick MM, Norman MA, et al. hypotensive resuscitation strategy reduces transfusion requirements and severe postoperative coagulopathy in trauma patients with hemorrhagic shock : preliminary results of a randomized controlled trial. J Trauma 2011 ; 70 : 652-63.
17) Malone DL, Hess JR, Fingerhut A. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. J Trauma 2006 ; 60 : S91-6.
18) Brain Trauma Foundation ; American Association of Neurological Surgeons ; Congress of Neurological Surgeons ; Joint Section on Neurotrauma and Critical Care, AANS/CNS, Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. III. Prophylactic hypothermia. J Neurotrauma 2007 ; 24 (suppl 1) ; S21-5.
19) Talmor D, Merkind V, Artru AA, et al. Treatments to support blood pressure increases bleeding and/or decreases survival in a rat model of closed head trauma combined with uncontrolled hemorrhage. Anesth Analg 1999 ; 89 : 950-6.
20) Bourguignon PR, Shackford SR, Shiffer C, et al. Delayed fluid resuscitation of head injury and uncontrolled hemorrhagic shock. Arch Surg 1998 ; 133 : 390-8.
P.471 掲載の参考文献
1) Hardy JF, de Moerloose P, Samama CM. The coagulopathy of massive transfusion. Vox Sang 2005 ; 89 : 123-7.
2) Gando S. Acute coagulopathy of trauma shock and coagulopathy of trauma : a rebuttal. You are now going down the wrong path. J Trauma 2009 ; 67 : 381-3.
3) Gando S, Sawamura A, Hayakawa M. Trauma, shock, and disseminated intravascular coagulation : lessons from the classical literature. Ann Surg 2011 ; 254 : 10-9.
4) Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989 ; 134 : 1087-97.
5) 丸藤哲, 澤村淳, 早川峰司ほか. 外傷急性期の血液凝固線溶系-現在の世界的論点を整理する-. 日救急医会誌 2010 ; 21 : 765-78.
6) Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma : a review of mechanisms. J Trauma 2008 ; 65 : 748-54.
7) Levrat A, Gros A, Rugeri L, et al. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth 2008 ; 100 : 792-7.
8) Tauber H, Innerhofer P, Breitkopf R, et al. Prevalence and impact of abnormal ROTEM (R) assays in severe blunt trauma : results of the 'Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study'. Br J Anaesth 2011 ; 107 : 378-87.
9) Theusinger OM, Wanner GA, Emmert MY, et al. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg 2011 ; 113 : 1003-12.
10) Kushimoto S, Shibata Y, Yamamoto Y. Implications of fibrinogenolysis in patients with closed head injury. J Neurotrauma 2003 ; 20 : 357-63.
11) Hayakawa M, Sawamura A, Gando S, et al. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase. Surgery 2011 ; 149 : 221-30.
12) Sawamura A, Hayakawa M, Gando S, et al. Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb Res 2009 ; 124 : 608-13.
13) 早川峰司, 和田剛志, 菅野正寛ほか. 鈍的外傷患者におけるFDP (fibrin/fibrinogen degradation products) 高値と大量出血の関連性. 日救急医会誌 2010 ; 21 : 165-71.
14) Paluszkiewicz P, Mayzner-Zawadzka E, Baranowski W, et al. Recommendations for the management of trauma or surgery-related massive blood loss. Pol Przegl Chir 2011 ; 83 : 465-76.
15) Hiippala S. Replacement of massive blood loss. Vox Sang 1998 ; 74 (suppl 2) : 399-407.
16) Gando S, Sawamura A, Hayakawa M. Trauma, shock, and disseminated intravascular coagulation : lessons from the classical literature. Ann Surg 2011 ; 254 : 10-9.
17) Shakur H, Roberts R, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) : a randomised, placebo-controlled trial. Lancet 2010 ; 376 : 23-32.
18) Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients : an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011 ; 377 : 1096-101.
19) Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients : two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005 ; 59 : 8-15.
20) Hauser CJ, Boffard K, Dutton R, et al. Results of the CONTROL trial : efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma 2010 ; 69 : 489-500.
21) McMullin NR, Wade CE, Holcomb JB, et al. Prolonged prothrombin time after recombinant activated factor VII therapy in critically bleeding trauma patients is associated with adverse outcomes. J Trauma 2010 ; 69 : 60-9.
22) Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008 ; 248 : 447-58.
23) Zink KA, Sambasivan CN, Holcomb JB, et al. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg 2009 ; 197 : 565-70.
24) Rowell SE, Barbosa RR, Diggs BS, et al. Effect of high product ratio massive transfusion on mortality in blunt and penetrating trauma patients. J Trauma 2011 ; 71 : S353-7.
25) Brown LM, Aro SO, Cohen MJ, et al. A high fresh frozen plasma : packed red blood cell transfusion ratio decreases mortality in all massively transfused trauma patients regardless of admission international normalized ratio. J Trauma 2011 ; 71 : S358-63.
26) Sambasivan CN, Kunio NR, Nair PV, et al. High ratios of plasma and platelets to packed red blood cells do not affect mortality in nonmassively transfused patients. J Trauma 2011 ; 71 : S329-36.
27) Watson GA, Sperry JL, Rosengart MR, et al. Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 2009 ; 67 : 221-7.
28) Sperry JL, Ochoa JB, Gunn SR, et al. An FFP : PRBC transfusion ratio>/=1 : 1. 5 is associated with a lower risk of mortality after massive transfusion. J Trauma 2008 ; 65 : 986-93.
29) Nienaber U, Innerhofer P, Westermann I, et al. The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury 2011 ; 42 : 697-701.
30) Martinowitz U, Michaelson M. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding : a report by the Israeli Multidisciplinary rFVIIa Task Force. J Thromb Haemost 2005 ; 3 : 640-8.
31) Stainsby D, MacLennan S, Thomas D, et al. Guidelines on the management of massive blood loss. Br J Haematol 2006 ; 135 : 634-41.
32) Vincent JL, Rossaint R, RiouB, et al. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding-a European perspective. Crit Care 2006 ; 10 : R120.
33) Spahn DR, CernyV, CoatsTJ, et al. Management of bleeding following major trauma : a European guideline. Crit Care 2007 ; 11 : R17.
34) Gaarder C, Naess PA, Frischknecht Christensen E, et al. Scandinavian Guidelines- "The massively bleeding patient". Scand J Surg 2008 ; 97 : 15-36.
35) Liumbruno G, Bennardello F, Lattanzio A, et al. Recommendations for the transfusion of plasma and platelets. Blood Transfus 2009 ; 7 : 132-50.
36) Roback JD, Caldwell S, Carson J, et al. Evidencebased practice guidelines for plasma transfusion. Transfusion 2010 ; 50 : 1227-39.
37) Thomas D, Wee M, Clyburn P, et al. Blood transfusion and the anaesthetist : management of massive haemorrhage. Anaesthesia 2010 ; 65 : 1153-61.
38) Rizoli SB, Boffard KD, Riou B, et al. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy : subgroup analysis from two randomized trials. Crit Care 2006 ; 10 : R178.
39) Christensen MC, Parr M, Tortella BJ, et al. Global differences in causes, management, and survival after severe trauma : the recombinant activated factor VII phase 3 trauma trial. J Trauma 2010 ; 69 : 344-52.
40) Rice TW, Morris S, Tortella BJ, et al. Deviations from evidence-based clinical management guidelines increase mortality in critically injured trauma patients. Crit Care Med 2012 ; 40 : 778-86.
41) Cameron P, Phillips L, Balogh Z, et al. The use of recombinant activated factor VII in trauma patients : Experience from the Australian and New Zealand haemostasis registry. Injury 2007 ; 38 : 1030-8.
42) Spinella PC, Perkins JG, Grathwohl KW, et al. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma 2009 ; 66 : S69-76.
43) Stanworth SJ, Morris TP, Gaarder C, et al. Reappraising the concept of massive transfusion in trauma. Crit Care 2010 ; 14 : R239.
44) Spoerke N, Michalek J, Schreiber M, et al. Crystalloid resuscitation improves survival in trauma patients receiving low ratios of fresh frozen plasma to packed red blood cells. J Trauma 2011 ; 71 : S380-3.
45) Holcomb JB, Zarzabal LA, Michalek JE, et al. Increased platelet : RBC ratios are associated with improved survival after massive transfusion. J Trauma 2011 ; 71 : S318-28.
46) Wafaisade A, Maegele M, Lefering R, et al. High plasma to red blood cell ratios are associated with lower mortality rates in patients receiving multiple transfusion (4 < red blood cell units < 10) during acute trauma resuscitation. J Trauma 2011 ; 70 : 81-8.

心肺蘇生

P.478 掲載の参考文献
1) Sayre MR, Koster RW, Botha M, et al. Part 5 : Adult basic life support : 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation 2010 ; 122 : S298-S324.
2) Nolan JP, Soar J, Zideman DA, et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary. Resuscitation 2010 ; 81 : 1219-76.
3) Vaillancourt C, Everson-Stewart S, Christenson J, et al. The impact of increased chest compression fraction on return of spontaneous circulation for out-of-hospital cardiac arrest patients not in ventricular fibrillation. Resuscitation 2011 ; 82 : 1501-7. Epub 2011 Jul 18.
4) Stiell IG, Brown SP, Christenson J, et al. What is the role of chest compression depth during out-of-hospital cardiac arrest resuscitation? Crit Care Med 2012 ; 40 : 1192-8.
5) Olasveengen TM, Sunde K, Brunborg C, et al. Intravenous drug administration during out-of-hospital cardiac arrest : a randomized trial. JAMA 2009 ; 302 : 2222-9.
6) Jacobs IG, Finn JC, Jelinek GA, et al. Effect of adrenaline on survival in out-of-hospital cardiac arrest : A randomised double-blind placebo-controlled trial. Resuscitation 2011 ; 82 : 1138-43. Epub 2011 Jul 2.
7) Hagihara A, Hasegawa M, Abe T, et al. Prehospital epinephrine use and survival among patients with out-of-hospital cardiac arrest. JAMA 2012 ; 307 : 1161-8. doi : 10.1001/jama.2012.294.
8) Ong ME, Tiah L, Leong BS, et al. A randomised, double-blind, multi-centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the emergency department. Resuscitation 2012 ; 83 : 953-60.
9) Stueven HA, Tonsfeldt DJ, Thompson BM, et al. Atropine in asystole : human studies. Ann Emerg Med 1984 ; 13 : 815-7.
10) Brown DC, Lewis AJ, Criley JM. Asystole and its treatment : the possible role of the parasympathetic nervous system in cardiac arrest. JACEP 1979 ; 8 : 448-52.
11) Coon GA, Clinton JE, Ruiz E. Use of atropine for brady-asystolic pre-hospital cardiac arrest. Ann Emerg Med 1981 ; 10 : 462-7.
12) DeBehnke DJ, Swart GL, Spreng D, et al. Standard and higher doses of atropine in a canine model of pulseless electrical activity. Acad Emerg Med 1995 ; 2 : 1034-41.
13) Sorensen M, Engbaek J, Viby-Mogensen J, et al. Bradycardia and cardiac asystole following a single injection of suxamethonium. Acta Anaesthesiol Scand 1984 ; 28 : 232-5.
14) Lovstad RZ, Granhus G, Hetland S. Bradycardia and asystolic cardiac arrest during spinal anaesthesia : a report of five cases. Acta Anaesthesiol Scand 2000 ; 44 : 48-52.
15) Tortolani AJ, Risucci DA, Powell SR, et al. In-hospital cardiopulmonary resuscitation during asystole. Therapeutic factors associated with 24-hour survival. Chest 1989 ; 96 : 622-6.
16) Stiell IG, Wells GA, Hebert PC, et al. Association of drug therapy with survival in cardiac arrest : limited role of advanced cardiac life support drugs. Acad Emerg Med 1995 ; 2 : 264-73.
17) Engdahl J, Bang A, Lindqvist J, et al. Can we define patients with no and those with some chance of survival when found in asystole out of hospital? Am J Cardiol 2000 ; 86 : 610-4.
18) Engdahl J, Bang A, Lindqvist J, et al. Factors affecting short-and long-term prognosis among 1069 patients with out-of-hospital cardiac arrest and pulseless electrical activity. Resuscitation 2001 ; 51 : 17-25.
19) van Walraven C, Stiell IG, Wells GA, et al. Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest? The OTAC Study Group. Ann Emerg Med 1998 ; 32 : 544-53.
20) Dumot JA, Burval DJ, Sprung J, et al. Outcome of adult cardiopulmonary resuscitations at a tertiary referral center including results of "limited" resuscitations. Arch Intern Med 2001 ; 161 : 1751-8.
21) N eumar RW, Otto CW, Link MS, et al. Part 8 : Adult advanced cardiovascular life support : 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010 ; 122 : S729-67.
22) Survey of Survivors After Out-of-hospital Cardiac Arrest in KANTO Area, Japan (SOS-KANTO) Study Group. Atropine sulfate for patients with out-of-hospital cardiac arrest due to asystole and pulseless electrical activity. Circ J 2011 ; 75 : 580-8.
23) Jacobs I, Sunde K, Deakin CD, et al. Part 6 : Defibrillation : 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation 2010 ; 122 : S325-37.
24) Stiell IG, Nichol G, Leroux BG, et al. Early versus later rhythm analysis in patients with out-of-hospital cardiac arrest. N Engl J Med 2011 ; 365 : 787-97.
25) Plaisance P, Lurie KG, Payen D. Inspiratory impedance during active compression-decompression cardiopulmonary resuscitation : a randomized evaluation in patients in cardiac arrest. Circulation 2000 ; 101 : 989-94.
26) Plaisance P, Lurie KG, Vicaut E, et al. Evaluation of an impedance threshold device in patients receiving active compression-decompression cardiopulmonary resuscitation for out of hospital cardiac arrest. Resuscitation 2004 ; 61 : 265-71.
27) Aufderheide TP, Pirrallo RG, Provo TA, et al. Clinical evaluation of an inspiratory impedance threshold device during standard cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest. Crit Care Med 2005 ; 33 : 734-40.
28) Wolcke BB, Mauer DK, Schoefmann MF, et al. Comparison of standard cardiopulmonary resuscitation versus the combination of active compression-decompression cardiopulmonary resuscitation and an inspiratory impedance threshold device for out-of-hospital cardiac arrest. Circulation 2003 ; 108 : 2201-5.
29) Thayne RC, Thomas DC, Neville JD, et al. Use of an impedance threshold device improves short-term outcomes following out-of-hospital cardiac arrest. Resuscitation 2005 ; 67 : 103-8.
30) Aufderheide TP, Nichol G, Rea TD, et al. A trial of an impedance threshold device in out-of-hospital cardiac arrest. N Engl J Med 2011 ; 365 : 798-806.
31) Cohen TJ, Goldner BG, Maccaro PC, et al. A comparison of active compression-decompression cardiopulmonary resuscitation with standard cardiopulmonary resuscitation for cardiac arrests occurring in the hospital. N Engl J Med 1993 ; 329 : 1918-21.
32) Lurie KG, Shultz JJ, Callaham ML, et al. Evaluation of active compression-decompression CPR in victims of out-of-hospital cardiac arrest. JAMA 1994 ; 271 : 1405-11.
33) Tucker KJ, Galli F, Savitt MA, et al. Active compression-decompression resuscitation : effect on resuscitation success after in-hospital cardiac arrest. J Am Coll Cardiol 1994 ; 24 : 201-9.
34) Plaisance P, Adnet F, Vicaut E, et al. Benefit of active compression-decompression cardiopulmonary resuscitation as a prehospital advanced cardiac life support : a randomized multicenter study. Circulation 1997 ; 95 : 955-61.
35) Plaisance P, Lurie KG, Vicaut E, et al. A comparison of standard cardiopulmonary resuscitation and active compression-decompression resuscitation for out-of-hospital cardiac arrest. French Active Compression-Decompression Cardiopulmonary Resuscitation Study Group. N Engl J Med 1999 ; 341 : 569-75.
36) He Q, Wan Z, Wang L. [Random control trial of the efficacy of cardiopump on pre-hospital cardiac arrest]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003 ; 15 : 292-4.
37) Lafuente-Lafuente C, Melero-Bascones M. Active chest compression-decompression for cardiopulmonary resuscitation. Cochrane Database Syst Rev. 2004 ; (2) : CD002751.
38) Peberdy MA, Callaway CW, Neumar RW, et al. Part 9 : Post-cardiac arrest care : 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010 ; 122 : S768-86.
39) Tagami T, Hirata K, Takeshige T, et al. Implementation of the fifth link of the chain of survival concept for out-of-hospital cardiac arrest. Circulation 2012 ; 126 : 589-97.
40) O'Connor RE, Bossaert L, Arntz HR, et al. Part 9 : Acute Coronary Syndromes : 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation 2010 ; 122 : S422-S65.
41) M arsala J, Marsala M, Vanicky I, et al. Post cardiac arrest hyperoxic resuscitation enhances neuronal vulnerability of the respiratory rhythm generator and some brainstem and spinal cord neuronal pools in the dog. Neurosci Lett 1992 ; 146 : 121-4.
42) Zwemer CF, Whitesall SE, D' Alecy LG. Cardiopulmonary-cerebral resuscitation with 100% oxygen exacerbates neurological dysfunction following nine minutes of normothermic cardiac arrest in dogs. Resuscitation 1994 ; 27 : 159-70.
43) Liu Y, Rosenthal RE, Haywood Y, et al. Normoxic ventilation after cardiac arrest reduces oxidation of brain lipids and improves neurological outcome. Stroke 1998 ; 29 : 1679-86.
44) Vereczki V, Martin E, Rosenthal RE, et al. Normoxic resuscitation after cardiac arrest protects against hippocampal oxidative stress, metabolic dysfunction, and neuronal death. J Cereb Blood Flow Metab 2006 ; 26 : 821-35.
45) Richards EM, Fiskum G, Rosenthal RE, et al. Hyperoxic reperfusion after global ischemia decreases hippocampal energy metabolism. Stroke 2007 ; 38 : 1578-84.
46) Richards EM, Rosenthal RE, Kristian T, et al. Postischemic hyperoxia reduces hippocampal pyruvate dehydrogenase activity. Free Radic Biol Med 2006 ; 40 : 1960-70.
47) Ferguson LP, Durward A, Tibby SM. Relationship between arterial partial oxygen pressure after resuscitation from cardiac arrest and mortality in children. Circulation 2012 ; 126 : 335-42. Epub 2012 Jun 21.
48) Janz DR, Hollenbeck RD, Pollock JS, et al. Hyperoxia is associated with increased mortality in patients treated with mild therapeutic hypothermia after sudden cardiac arrest. Crit Care Med 2012 ; 40 : 3135-9.
49) Kilgannon JH, Jones AE, Shapiro NI, et al. Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. JAMA 2010 ; 303 : 2165-71.
50) Kuisma M, Boyd J, Voipio V, et al. Comparison of 30 and the 100% inspired oxygen concentrations during early post-resuscitation period : a randomised controlled pilot study. Resuscitation 2006 ; 69 : 199-206.
51) Bellomo R, Bailey M, Eastwood GM, et al. Arterial hyperoxia and in-hospital mortality after resuscitation from cardiac arrest. Crit Care 2011 ; 15 : R90.
53) Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002 ; 346 : 557-63.
54) Castrejon S, Cortes M, Salto ML, et al. Improved prognosis after using mild hypothermia to treat cardiorespiratory arrest due to a cardiac cause : comparison with a control group. Rev Esp Cardiol 2009 ; 62 : 733-41.
55) Sunde K, Pytte M, Jacobsen D, et al. Implementation of a standardised treatment protocol for post resuscitation care after out-of-hospital cardiac arrest. Resuscitation 2007 ; 73 : 29-39.
56) Rittenberger JC, Guyette FX, Tisherman SA, et al. Outcomes of a hospital-wide plan to improve care of comatose survivors of cardiac arrest. Resuscitation 2008 ; 79 : 198-204.
57) Wolff B, Machill K, Schumacher D, et al. Early achievement of mild therapeutic hypothermia and the neurologic outcome after cardiac arrest. Int J Cardiol 2009 ; 133 : 223-8.
58) Bernard SA, Smith K, Cameron P, et al. Induction of therapeutic hypothermia by paramedics after resuscitation from out-of-hospital ventricular fibrillation cardiac arrest : a randomized controlled trial. Circulation 2010 ; 122 : 737-42. Epub 2010 Aug 2.
59) Bernard SA, Smith K, Cameron P, et al. Induction of prehospital therapeutic hypothermia after resuscitation from nonventricular fibrillation cardiac arrest. Crit Care Med 2012 ; 40 : 747-53.
60) Morrison LJ, Kierzek G, Diekema DS, et al. Part 3 : ethics : 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010 ; 122 : S665-S75.
61) Goldberger ZD, Chan PS, Berg RA, et al, for the American Heart Association Get With The Guidelines-Resuscitation (formerly the National Registry of Cardiopulmonary Resuscitation) Investigators. Duration of resuscitation efforts and survival after in-hospital cardiac arrest : an observational study. Lancet 2012 ; 380 : 1473-81.
P.489 掲載の参考文献
1) Phillips SJ, Ballentine B, Slonine D, et al. Percutaneous initiation of cardiopulmonary bypass. Ann Thorac Surg 1983 ; 36 : 223-5.
2) Cave DM, Gazmuri RJ, Otto CW, et al. Part 7 : CPR Techniques and Devices : 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010 ; 122 : S720-S8
3) 日本蘇生協議会, 日本救急医療財団. JRC 蘇生ガイドライン 2010. へるす出版, 2011, 446.
4) Kleinman ME, Chameides L, Schexnayder SM, et al. Part 14 : Pediatric Advanced Life Support : 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010 ; 122 : S876-S908
5) Nichol G, Karmy-Jones R, Salerno C, et al. Systematic review of percutaneous cardiopulmonary bypass for cardiac arrest or cardiogenic shock states. Resuscitation 2006 ; 70 : 381-94.
6) Tibballs J, Kinney S. A prospective study of outcome of in-patient paediatric cardiopulmonary arrest. Resuscitation 2006 ; 71 : 310-8.
7) Berg MD, Nadkarni VM, Berg RA. Cardiopulmonary resuscitation in children. Curr Opin Crit Care 2008 ; 14 : 254-60.
8) Foltin GL, Richmond N, Treiber M, et al. Pediatric Prehospital Evaluation of NYC Cardiac Arrest Survival (PHENYCS). Pediatr Emerg Care 2012 ; 28 : 864-8.
9) Young KD, Seidel JS. Pediatric cardiopulmonary resuscitation : a collective review. Ann Emerg Med 1999 ; 33 : 195-205.
10) Herlitz J, Engdahl J, Svensson L, et al. Characteristics and outcome among children suffering from out of hospital cardiac arrest in Sweden. Resuscitation 2005 ; 64 : 37-40.
11) Chen YS, Lin JW, Yu HY, et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest : an observational study and propensity analysis. Lancet 2008 ; 372 : 554-61.
12) Tanno K, Itoh Y, Takeyama Y, et al. Utstein style study of cardiopulmonary bypass after cardiac arrest. Am J Emerg Med 2008 ; 26 : 649-54.
13) Lin JW, Wang MJ, Yu HY, et al. Comparing the survival between extracorporeal rescue and conventional resuscitation in adult in-hospital cardiac arrests : propensity analysis of three-year data. Resuscitation 2010 ; 81 : 796-803.
14) Shin TG, Choi JH, Jo IJ, et al. Extracorporeal cardiopulmonary resuscitation in patients with inhospital cardiac arrest : A comparison with conventional cardiopulmonary resuscitation. Crit Care Med 2011 ; 39 : 1-7.
15) Kurose M, Okamoto K, Sato T, et al. The determinant of severe cerebral dysfunction in patients undergoing emergency extracorporeal life support following cardiopulmonary resuscitation. Resuscitation 1995 ; 30 : 15-20.
16) Nagao K, Hayashi N, Arima K, et al. Effects of combined emergency percutaneous cardiopulmonary support and reperfusion treatment in patients with refractory ventricular fibrillation complicating acute myocardial infarction. Intern Med 1999 ; 38 : 710-6.
17) Jaski BE, Lingle RJ, Overlie P, et al. Long-term survival with use of percutaneous extracorporeal life support in patients presenting with acute myocardial infarction and cardiovascular collapse. ASAIO J 1999 ; 45 : 615-8.
18) Ruttmann E, Weissenbacher A, Ulmer H, et al. Prolonged extracorporeal membrane oxygenationassisted support provides improved survival in hypothermic patients with cardiocirculatory arrest. J Thorac Cardiovasc Surg 2007 ; 134 : 594-600.
19) Chen YS, Yu HY, Huang SC, et al. Extracorporeal membrane oxygenation support can extend the duration of cardiopulmonary resuscitation. Crit Care Med 2008 ; 36 : 2529-35.
20) Shinn SH, Lee YT, Sung K, et al. Efficacy of emergent percutaneous cardiopulmonary support in cardiac or respiratory failure : fight or flight? Interact Cardiovasc Thorac Surg 2009 ; 9 : 269-73.
21) Kagawa E, Inoue I, Kawagoe T, et al. Assessment of outcomes and differences between in-and out-of-hospital cardiac arrest patients treated with cardiopulmonary resuscitation using extracorporeal life support. Resuscitation 2010 ; 81 : 968-73.
22) Ferrari M, Hekmat K, Jung C, et al. Better outcome after cardiopulmonary resuscitation using percutaneous emergency circulatory support in non-coronary patients compared to those with myocardial infarction. Acute Card Care 2011 ; 13 : 30-4.
23) Hashiba K, Okuda J, Maejima N, et al. Percutaneous cardiopulmonary support in pulmonary embolism with cardiac arrest. Resuscitation 2012 ; 83 : 183-7.
24) Kagawa E, Dote K, Kato M, et al. Should we emergently revascularize occluded coronaries for cardiac arrest? : rapid-response extracorporeal membrane oxygenation and intra-arrest percutaneous coronary intervention. Circulation 2012 ; 126 : 1605-13.
25) Masson R, Colas V, Parienti JJ, et al. A comparison of survival with and without extracorporeal life support treatment for severe poisoning due to drug intoxication. Resuscitation 2012 ; 83 : 1413-7.
26) Nichol G, Karmy-Jones R, Salerno C, et al. Systematic review of percutaneous cardiopulmonary bypass for cardiac arrest or cardiogenic shock states. Resuscitation 2006 ; 70 : 381-94.
27) Cardarelli MG, Young AJ, Griffith B. Use of extracorporeal membrane oxygenation for adults in cardiac arrest (E-CPR) : a meta-analysis of observational studies. ASAIO J 2009 ; 55 : 581-6.
28) Thiagarajan RR, Brogan TV, Scheurer MA, et al. Extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in adults. Ann Thorac Surg 2009 ; 87 : 778-85.
29) Morimura N, Sakamoto T, Nagao K, et al. Extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest : A review of the Japanese literature. Resuscitation 2011 ; 82 : 10-4.
30) Yu HY, Yeh HL, Wang SS, et al. Ultra long cardiopulmonary resuscitation with intact cerebral performance for an asystolic patient with acute myocarditis. Resuscitation 2007 ; 73 : 307-8.
31) Duncan BW, Ibrahim AE, Hraska V, et al. Use of rapid-deployment extracorporeal membrane oxygenation for the resuscitation of pediatric patients with heart disease after cardiac arrest. J Thorac Cardiovasc Surg 1998 ; 116 : 305-11.
32) Morris MC, Wernovsky G, Nadkarni VM. Survival outcomes after extracorporeal cardiopulmonary resuscitation instituted during active chest compressions following refractory in-hospital pediatric cardiac arrest. Pediatr Crit Care Med 2004 ; 5 : 440-6.
33) Thiagarajan RR, Laussen PC, Rycus PT, et al. Extracorporeal membrane oxygenation to aid cardiopulmonary resuscitation in infants and children. Circulation 2007 ; 116 : 1693-700.
34) Alsoufi B, Al-Radi OO, Nazer RI, et al. Survival outcomes after rescue extracorporeal cardiopulmonary resuscitation in pediatric patients with refractory cardiac arrest. J Thorac Cardiovasc Surg 2007 ; 134 : 952-9. e2.
35) Kane DA, Thiagarajan RR, Wypij D, et al. Rapidresponse extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in children with cardiac disease. Circulation 2010 ; 122 (11 suppl) : S241-8.
36) Raymond TT, Cunnyngham CB, Thompson MT, et al. Outcomes among neonates, infants, and children after extracorporeal cardiopulmonary resuscitation for refractory inhospital pediatric cardiac arrest : a report from the National Registry of Cardiopulmonary Resuscitation. Pediatr Crit Care Med 2010 ; 11 : 362-71.
37) Delmo Walter EM, Alexi-Meskishvili V, Huebler M, et al. Rescue extracorporeal membrane oxygenation in children with refractory cardiac arrest. Interact Cardiovasc Thorac Surg 2011 ; 12 : 929-34.
38) Tajik M, Cardarelli MG. Extracorporeal membrane oxygenation after cardiac arrest in children : what do we know? Eur J Cardiothorac Surg 2008 ; 33 : 409-17.
39) Booth KL, Roth SJ, Thiagarajan RR, et al. Extracorporeal membrane oxygenation support of the Fontan and bidirectional Glenn circulations. Ann Thorac Surg 2004 ; 77 : 1341-8.
40) Rood KL, Teele SA, Barrett CS, et al. Extracorporeal membrane oxygenation support after the Fontan operation. J Thorac Cardiovasc Surg 2011 ; 142 : 504-10.
41) http://www.save-j.net
42) Belohlavek J, Kucera K, Jarkovsky J. Hyperinvasive approach to out-of hospital cardiac arrest using mechanical chest compression device, pre hospital intraarrest cooling, extracorporeal life support and early invasive assessment compared to standard of care. A randomized parallel groups comparative study proposal. "Prague OHCA study" J Transl Med 2012 ; 10 : 163.

最近チェックした商品履歴

Loading...